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CHAPTER 1 
INTRODUCTION AND REVIEW OF THE LITERATURE 
l 
1 - INTRODUCTION AND REVIEW OF THE LITERATURE 
1. INTRODUCTION 
This work was car'ried out in the Neonatal Intensive Care Unit at 
Groote Schuur Hospital, Cape Town, from July, 1972, to December, 1973, 
under the guidance of Dr. A.F. Malan. This was a newly opened Unit for 
Coloured and African Neonates requiring special care, well-equipped with 
trained staff and good monitoring apparatus • .' For the first time it was 
possible to provide facilities for patient care in line with those avail-
able abroad. 
The problem of feeding preterm infants has interested many authors 
(Abramowicz, 1966; Babson, 1971; Gamsu, 1972). The ideal quantity, 
content of nutrients, calorific value and mode of administration of feeds 
remains, at best, approximate. With the advent of Total Parenteral 
Nutrition (TPN) and the availability of relatively safe ' solutions of 
fats and amino-acids for intravenous use, interest has been stimulated 
in the optimal nutrient and caloric requirements of the growing infant. 
The Department of Paediatrics and Child Health of the University 
of Cape Town is responsible for the care of approximately 12,000 in-born 
infants per annum. In 1971 (prior to the opening of the Unit) 139 infants 
were born in Groote Schuur Hospital Maternity Block who weighed less than 
1500 grams or whose gestational age was less than 32 weeks. Their mothers 
were mostly from the lower socio-economic sections of the population. The 
neonatal mortality for low birth mass (LBM) infants less than 29 weeks 
gestation was 90% (Fig. 1) and for those between 29 and 32 weeks (1001 to 
1500 g) was 51%. This compares favourably with results from other centres 
(Washington, 1970; Alden, 1972). 
1 
Fig. 1. 
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The motor and mental development of the babies is even more 
important than the total number of survivors. The high incidence of mental 
retardation, motor defects as vell as minor neurological problems is 
disturbing, but should be regarded as a stimulus to more vigorous efforts 
to improve the management of LBM babies. 
Many factors which are now largely manageable contributed to the 
high morbidity in the past. Some of these were delayed feeding, excessive 
oxygen administration, hyperbilirubinaemia, hypoglycaemia, choice of antibiotics 
and low ambient incubator temperature. 
Long-term follow up of survivors has demonstrated lower intelligence 
quotient · scores and increased incidence of perceptual and motor deficits 
when compared with larger pre- and full-term infants (Drilli~n, 1994; 
McDonald, 1967; Lubchenco, 1972). Encouraging follow-up studies by Rawlings, 
(1971), on infants treated by controlled intensive care indicates its benefits. 
Recent evidence in human beings (Stach, 1967; Davies, 1970) and animals 
(Winick, 1966) suggests that early post natal malnutrition may permanently 
impair brain growth. 
1. ORAL FEEDING PRACTICES 
The LBM infant has an increased requirement for calories per unit 
of body mass, whether he is prematurely born or small for gestational age 
{Babson, 1971). Most LBM infants cannot accept these basic requirements 
by mouth during the first few days of life and in some an intake sufficient 
to -support growth may not be reached for many weeks (Ghadimi, 1971). 
Initially this inability to accept the correct volume of milk feeds was 
regarded as good reason for delay in the onset of feeding as much as 48 
hours (Smith, 1957). This avoided complications such as vomiting, inhalational 
bronchopneumonia and apnoeic attacks. Davies (1970) showed a relationship 
between delayed feeding practices and subsequent growth in head size. With 
the realisation that early adequate calories were essential to support the 
high risk infant for the first few days, the practice of early feeding from 
two hours after birth became popular (Smallpiece, 1964). 
Sick preterm high risk infants may be unable to tolerate early 
adequate oral feeding . A reduction in neonatal mortality was demonstrated by 
supplementation of the feed with intravenous infusion of a 10% glucose 
solution immediately after birth (Cornblath, 1966 b; Kitchen, 1971). Early 
feeding has produced a significant reduction in weight loss, hyperbilirubinaemia 
and hypoglycaemia (Smallpiece, 1964; Warton, 1965). Unfortunately 
supplemental intravenous glucose does not provide adequate calories 
to support active growth, and should be regarded as a temporary procedure. -
Nutritional requirements and oral feeding. 
In order for the growth rate of the preterm infant to approach the 
appropriate intrauterine rate, it is necessary for the formula to ~ave a 
-caloric and nutritional content greater than .that found in human milk 
(Babson, 1971). 
The exact caloric requirements of preterm infants are unknown but 
the currently accepted range is between 120 and 180 calories/kg/day 
(Holt, 1961; ~~yderman, 1961; Sinclair, 1970, Gamsu, 1972; Heird, 1972). 
If the caloric concentration of the milk formula were similar to that of 
human milk, the volume required could cause feeding difficulties by 
exceeding the infant's gastric capacity. "Humanised" mi1k feeds provide 
approximately 70 cal/100 ml whereas breast milk provides 65 cal/100 ml. 
These high caloric formulae contain a low solute load so that the renal 
excretory capacity is not overloaded. Gordon and Levine (1944) recommended 
proV,isbn of 120 calories in 150 mls of water per kilogram per day; this 
regimen is widely used. 
Linear growth is reduced vhen preterm infants are fed lov protein 
intakes under 2,5 gjk:g/day (Babson, 1969). Conversely high intakes of protein 
may raise the blood urea nitrogen excessively, promote hyperaminoacichemia 
increase the urinary osmolar load, and produce protein "intoxication" 
(Om~s, 1961). Currently accepted protein intake is approximately 3 - 4 
g/kg/day in paediatric patients (Holt, 1961; Davidson, 1967). 
The high content of unsaturated fatty acids provided by vegetable oil 
in 11 humanised 11 milks promotes intestinal absorption. Fat may provide up to 
50% of the caloric requirement in formulae for preterm infants. 
Cubobydrate·s should supply approximately 4Cf'/o of the caloric requirement. 
Formulae containing over 12% carbohydrate may produce diarrhpea (Babson, 1971). 
The limited concentrating ability of the neonatal kidney and the 
increased demand for preurinary water in the preterm infant suggests the need 
for low ash formulae. Conversely, the preterm infant's demineralised state 
and increased potential for gro,vth theoretically increase the requirements 
for minerals and electrolytes. The concentration of minerals and electrolytes 
should be in between those of human and of cow's milk. Trace elements 
(except iron) sufficient for grovth are found in most milk mixtures. 
Iron is regarded as an essential mineral in LBM infants and the daily 
minimum requirement ranges from 4 mg/kg/day at birth (Gamsu, 1972) to 
10-15 mg/kg/day at one month (Babson, 1971). 
The LBM infant requires early multiple vitamin supplementation 
(Gamsu, 1972) which should be commenced as soon as milk feedings are begun. 
Recommended daily amounts of vitamins are indicated in Table III and 
I 
contrasted with a "humanised" milk formula currently used for oral feeding;.,; 
2. PARENTERAL FEEDING 
The first documented report of success in TPN in an infant was 
published by Helfrich and Abelson in 1944. During the next 20 years many 
tried to duplicate this impressive result, usually 'Without success. 
In 1966 Dudrick and his co-workers devised a method by which a 
catheter could be implanted and maintained in the superior vena cava for long 
periods of time. By using a large vein with high blood flow he surmised that 
the hyperosmolar nutritive fluid, given by slow continuous infusion, would be 
effectively diluted and tht1s avoid damaging the vein (Dudrick, 1968). Using 
this method of delivery and a hypertonic glucose-protein hydrolysate fluid 
to which electrolytes, minerals and vitamins were added, he demonstrated that 
sustained grovth could be achieved in infants (Wilmore and Dudrick, 1968). 
Present indications for TPN 
This method of TPN was initially applied to surgical patients (Dudrick, 
1969),principally infants with anomalies of the gastro-intestinal tract. 
Later the principle was applied to infants with chronic intractable diarrhoea 
5 
\.lit h equal success (Hyman, 1971). In such infants TPN produces 11 bowel rest 11 
and coW1teracts the malnutrition caused by malabsorption of nutrients. 
This enables regeneration of the gastro-intestinal mucosa to take place and 
subsequent normal absorption and utilisation of oral nutrients. 
TPN is also described in acute renal failure in adult patients 
(Wilmore, 1969 a; Abel; 1973). No systematic study of this type of TPN 
in paediatrics has appeared in the literature at the time of vriting. 
TPN in LBM infants is the final possible indication. At the present 
t his procedure as a means of supporting LBM infants is regarded as 
strict ly investigational and certainly not as accepted part of routine 
neonatal care . 
TPN i n LBM i nfant s 
Reports have appeared in the literature of LBM infants treated 
successfully Yith TPN, the most important of which .rill. be mentioned. 
In a study of TPN in 53 critically ill children, Filler, (1970) 
included three preterm infants weighing less than 1000 g Yith gastro-
intestinal abnormalities. He used 27 g sugar/kg/day and 4,4 g protein/kg/day. 
One i nfant survived. The other two died of candida septicaemia. He did, 
however, demonst rate that weight gain can .be expected in those who are not 
infected. The trial was W1controlled. 
Benda (1971) attempted peripheral TPN using scalp veins in 14 infants 
W1der 1250 g on the second or third day of life. His infusate (Casein 
hydrolysate) provided 80 to 120 cal/kg/day. Simultaneous oral feeding was 
given. Increased weight gain was demonstrated compared Yith a control group 
and the initial weight loss over the first three days was minimised. No 
observations of osmolality, amino-acid excretions and acid base balance 
were 1p.ade~: There was no significant difference in mortality rate. This was 
not 1~tr ue 11 TPN as supplemental oral feeding was given. 
Bryan (1971) also reported a controlled study of TPN in preterm 
infants less than 1300 g. A fibrin hydrolysate was used intravenously to 
supplement the oral formula for the first 2 weeks. The total fluid intake 
was 200 ml/kg/day and the protein intake of the TPN group was twice that of 
6 
the controls. He also demonstrated no difference in mortality between the 
two groups. Time to regain birth weight was more rapid (14 days compared 
wit h 22 days) but the increased volume intake of the TPN group was not 
taken into account . He reported elevations of total protein and blood 
urea nitrogen levels and decrease in serum phosphate level in the TPN 
group. 
Driscoll (1972) reported a preliminary trial of TPN in 9 .LBM 
infants weighing less than 1150 g. Four died. The incidence of infection 
was 11%. Almost all infants developed chronic respiratory acidosis probably 
due to pulmonary insufficiency. The blood urea nitrogen rarely became 
elevated if less than 4 grams of protein/kg/day was given. Later, Driscoll 
compared these infants with suitable controls. He observed that once an 
intake of more than 100 cal/kg/day was achieved, sustained weight gain and 
positive nitrogen balance were achieved. Two cases became dehydrated due 
to osmotic diuresis following hyperglycaemia, one died from candida 
septicaemia, and three died from pulmonary insufficiency. The sample number 
in the trial was small and he could only conclude that further careful 
clinical investigation of TPN in LBM infants was required. 
Duncan (1972) demonstrated that post natal growth could approximate 
intrauterine growth if LBM infants were given TPN supplementation to the 
normal milk feeding regime. His study was an uncontrolled report on 7 
infants weighing less than 1500 grams. The scalp veins were used and 
Intralipid (a commercial fat emulsion infusion), casein hydrolysate and 
dextrose was infused from 6 to 25 days. Six infants survived. This was 
the first report of the use of intravenous fat emulsion in LBM infants. 
Elevated blood cholesterol levels were noted. There was a noticeable 
absence of infective complications when peripheral veins were used. This 
study was not controlled, but confirmed previou~ impressions that there 
were minimal metabolic derangements in electrolytes, liver function tests 
and blood coagulation. 
The largest study of TPN in LBM infants was reported by Subramanyam 
(1972) when 55 i nfant s below 1500 g body mass received supplemental TPN 
by peripheral vein together 'With oral milk feeds. This study was controll ed. 
Those receiving TPN gained significantly more weight and were discharged . 
home sooner than milk-fed controls. There was no significant difference in 
mort ality. No parallel biochemical or aminoacid studies were performed. 
Peden (1972) observed an average weight gain of 15 grams/day in 13 
preterm infants weighing less than 1700 grams . The external jugular vein 
was used. She not ed that hyperglycaemia was observed if the rate of 
i nfusion of glucose exceeded 0,8 to 0,9 g/kg/hr. 
Although a faster return to birth weight may be expected, :Bryan 
(1973) was unable to show any stat ist ically signif icant di f ference in growth 
between LBM infant s receiving supplemental TPN and milk-fed controls. 
He showed that the amount of weight gained vas proportional to the total 
daily nitrogen ip.take. This vas also the first report of a generalised 
aminoacidaemia in LBM infants folloving TPN. The incidence of septicaemia 
vas high using the umbilical vein for catheterisation. This is the most 
detailed published report to date. Unfortunately the infants receiving 
TPN were also given oral milk feeds so that "true" TPN and oral feeding 
cannot be compared 'With respect to biochemical parameters. 
From the available reports it would seem that a number of major 
questions concerning TPN remains unansvered. It appears that better amino 
acid solut ions are needed. Better caloric sources are also required. The 
use of intravenous fat emulsions as a rich source of calories holds promise. 
Shaw (1973) has used up to 4 g/kg/day 'Without untoward effect, yet the 
upper metabolic limit for clearance of the infused fat is unknown. Precise 
def initions of parenteral requirements for essential fatty acids, vitamins 
and trace minerals are needed. Little is known about endocrine and 
metabolic responses under the conditions of TPN in vhich the gastro-intestinal 
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tract and liver are by-passed. There is also a need for a more accurate 
definition of indications and contra-indications for TPN in LBM infants. 
The Parenteral Fluid 
Many TPN solutions for paediatric use have been proposed (Filler, 
1969; Wilmore, 1969; Borreson, 1970; Driscoll, 1972; Heird, 1972; Helmuth, 
1972; Peden, 1972; Shils, 1972; Wei, 1972; Bryan, 1973; Shaw, 1973). The 
principal difference between these solutions depends on the inclusion o~ 
exclusion of fat emulsion as a source of calories. At present these are 
available in Canada, Sweden and South Africa, ,but undergoing restricted 
trial in Great Britain and the United States of America. 
(a) Caloric content 
If Intralipid is not· available, high caloric contents are achieved 
by raising the concentration of sugar in the solution to as high as 20% 
(Filler, 1969; Nakajima, 1973). 
Glucose is the most commonly used sugar(Filler, 1970; Harries, 1971 a; 
Driscoll, 1972; Subramanyam, 1972; Shaw, 1973) in concentrations from 10-25%. 
The maximum concentration of glucose is governed by the appearance of hyper-
glycaemia which occurs when the infusion rate exceeds 0,9-1,25 g/kg/hr. 
(Duncan, 1972; Peden, 1972). 
The maximum infusion rate for fructose appears to be 0,3 g/kg/hr 
(Harries, 1971 a) limiting its usefulness in providing calories. Fructose 
infusions produce a higher increase in blood lactose and pyruvate levels 
(Geyer, 1960) and predispose to metabolic acidosis (Harries, 1971; 
Kekom'a.ki ; 1972) • 
Alcohol is a good source of calories (7 cal/g) but is toxic in infants 
and may produce increased losses of urine due to inhibition of ADH release 
(Harries, 1971). For these reasons Amigen 800 (Baxter Laboratories) would 
appear unsuitable for use in infants as it contains alcohol and fructose. 
The daily caloric requirement given by TPN would appear to be the 
I 
same as that required in oral feeding (page 29.) 
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(b) Proteins 
Although the allowance of infused aminoacids is 4-5 g/kg/ day in 
older infants (Heird, 1972; Helmuth, 1972), lower concentrations are considered 
safer in LBM babies (see above). Duncan, (1972) found that an intake of 
more than 4 g/kg/day produced azotaemia. Free aminoacids are available in 
hydrolysates of casein or fibrin and several preparations are in current use. 
More recently synthetic crysta]]i.ne amino acid' solutions have been under 
trial (Freamine). These would appear to have the advantage of lower ammonia 
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and peptide levels, but their superiority has yet to be evaluated. The advantages 
and disadvantages of the casein hydrolysate used in this trial will be discussed 
in Chapter V. In addition, the effect of the TPN solution on . plasma 
acid levels will be evaluated. (Chapter V) 
(c) Fat 
The availability of iso-osmotic Intralipid 10% (1,1 cal/ml) 
allows for the provision of up to 4 g/kg/day of fat or 32% of the total 
calories~ This concentration has been used in LBM infants without major 
side effects (Borreson, 1970; Harries, 1971a; Duncan, 1972). Gustafsen (1972) 
has sho\Jll that the removal capacity of fat from the . intravascular compartments 
in preterm infants is in the normal range for adults. Nitrogen balance studies 
show that Intralipid produces a significant nitrogen sparing effect in 
patients who are in negative nitrogen balance (Reid, 1967). In Intralipid, 
85% of the fatty acids are unsaturated, the predominant source being linoleic 
acid. Long term infusions reveal very few acute or late effects in adults 
(Schuberth, 1964; Wretlind, 1964) but changes in blood coagulability have 
been reported (Amris, 1964). This study serves as a report on the use of 
Intralipid in LBM infants on a large scale, the provision of linoleic acid 
in the _infusate obviates the syndrome of essential fatty acid deficiency 
induced by fat-free intravenous feeding which has been reported (PauJs:ud, 1972). 
(d) Vitamins 
The average daily intravenous requirement of many vitamins for 
newborns is not established. There is reason to expect that the individual 
doses are lower than those recommended by oral route. It is essential that 
adequate vitamin supplementation is added to the TPN regime. Suggested 
minimal daily requirements, notably by Borreson (1970) and Heird (1972) 
are tabulated in Table VII, page 31. 
(e) Miner als and electrolytes 
The mineral and electrolyte composition of each TPN solution 
varies 'Widely. The specific requirements for LBM infants together 'With the 
effect of the TPN on the serum levels of these electrolytes and minerals 
will be discussed in Chapter III. Trace elements are usually supplied by 
weekly infusions of plasma. The need for this in short term (7 to 10 days) 
TPN is debatable. 
The choice of; suitable TPN fluids is also governed by practical 
considerations. In this study Amigen 5% in 5% Dextrose Water (Baxter 
Laboratories) was selected as this solution was freely available. A 
I detailed description of this solution appears in Chapter II. 
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SCOPE OF THE THESIS 
No controlled trial of TPN in LBM inf ants . . has been reported at 
the time of writing as far as we are aware. For this reason it was decided 
to carry out a controlled trial of TPN in LBM infants using as the control 
an oral milk feeding regime of accepted type. 
(a) By studying the mortality and morbidity it ~as hoped to determine if 
there is a place for TPN in the management of LBM infants. 
(b) If this is so, is this applicable only in hospitals with special care 
facilities or could it be used in the routine care of such infants in a 
developing country? 
(c) The importance and relationship of several assoe·:tated factors md their 
bearing on mortality and morbidity was also studied. These were the 
effect of the intensive care that the babies received, . and perinatal 
infection. The .. perinatal infective environment, an important factor 
in determining mortality and morbidity in these infants, is discussed 
separately in Chapter I.V. 
(d) An attempt was made to determine whether TPN could support physical 
growth and development of these infants as effectively as oral milk feeding. 
(e) The biochemical effects of TPN were contr.asted with normal biochemical 
values determined for LBM infmts. In particular, the influence of TPN 
on plasma amino acid levels formed an important part of this study. The 
significance of altered plasma and amino acid levels and the suitablity 
of current parenteral amino acid solutions is discussed in Chapter v. 
(f) A short-term follow up study of survivors was carried out. 
CHAPTER II 
MATERIALS AND METHODS. 
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II - MATERIALS AND MEl'HO DS 
1. GENERAL NURSERY CARE 
The Intensive Care Unit is equipped to manage 8 to 10 infants. 
Being a referral centre, LBM infants were received from other maternity 
hospitals in the city. Mindful of the detrimental effect of transporting 
critically ill infants, care was taken to transport them under optimal 
conditions providing oxygen, warmth and intravenous fluids and utilising 
a modern transport incubator (Cunningham, 1973). 
On admission the infants were weighed with the same nursery scale 
(graduated in 10 g intervals) which was checked frequently for accuracy. 
They were placed in single-walled perspex incubators (Drager) whose tempera~ures 
were maintained at 33-35°C depending on the mass of the infant. The scheme 
of suggested incubator temperatures to ensure approximate isothermic 
conditions as ~proposed by Hey (Hey, 1972) was adopted(Appendix, Table 11). 
Since it has been shown that survival rates of preterm infants can be 
raised by decreasing heat loss (Silverman, 1958), abdominal skin temperature 
was maintained at 35-36°c in an attempt to achieve a neutral thermal 
environment (Mestyan, 1964; Oliver, 1965). A temperature thermistor with 
skin electrode (Yellow Springs) was used to monitor skin temperature. The 
accuracy of this instrument was found to be acceptable (See Appendix, Table 111). 
Within the first two hours, usually within 30 minutes, a scalp vein 
infusion was commenced with 10% Invert Sugar (Baxter), to a maximum volume 
of 60 ml/kg/day. It is important to provide adequate fluid and calories soon 
after birth (Cornblath, 1966) • • This has 'resulted in a significant reduction in 
the mort ality ~of infants less t han 1250 g (Cornblath, 1966 c). With caloric 
deprivation, blood glucose values may fall to subnormal levels (Beard, 1966; 
Mamunes, 1969) and ketonuria may be present in preterm infants. Deprivation 
of f luid and calories in the first 24 hours, especially in infants with low 
Apgar rates may be associated with prolonged acidosis and early hypernatraemia 
(Beard, 1963). Our infants received nothing by mouth for the .first 24 hours. 
If there was evidenc~ of respiratory distress, or clinical cyanosis, 
oxygen was given by means of a perspex head box (See fig. 2) 
1 3 
Fig. 2. 
PERSPEX HEAD BOX FOR OXYGEN AIMINISTRATION 
which enabled adjustable concentrations of oxygen to be delivered at low 
I 
flow rates. Generally an inspired oxygen concentration (Fi02 ) of 25-30% 
was used until arterial oxygen levels (pA0 2) were estimated, whereupon the 
precise Fi02 could be given to maintain the pA02 between 60 and 80 mm.Hg. 
The Fi02 was checked intermittently by paramagnetic oxygen analysers (Beckman 
Instruments) or in some cases continuously by a continuous-reading analyser 
(Ivac Corp.) 'With alarms for high and low oxygen levels. These instruments 
were regularly checked and serviced and proved to be reliable. Oxygen should 
be humidified to minimise evaporative water loss (Klaus, 1966). No water 
was placed in the incubators, however, as the humidity of the environment is 
50- 60%. 
Catheter inser tion 
Umbilical arterial catheterisation has been 'Widely practised for 
the l ast 15 years (James, 1959). It was decided to use arterial catheterisation 
i n preference to venous catheterisation firstly because the former allowed 
frequent pA02 estimations and secondly, because the complication ~ate is 
lower than with venous catheters (Symansky, 1972). 
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Within six hours of birth all infants had catheters inserted. 
Technique 
With special attention to the umbilicus the skin of the abdomen 
was swabbed with 7Cf/o alcohol. Under strictly aseptic conditions the site 
was draped and the umbilical card transected 1 cm from the abdominal wall. 
The edges were held with mosquito forceps and an umbilical arte.ry 
identified and gently dilated with a pair' of fine forceps. This 'Was 
found to be more successful than using the conventional probe. An Argyle 
3,5 French Umbilical Arterial Catheter (Aloe Medical) was slo'Wly introduced 
into the arterial lumen by non-touch technique. The sudden appearance of 
pulsating blood in the catheter confirmed correct cannul.ation, and the 
catheter was advanced 12-15 cm using the 5 cm marks as a reference. 
An adhesive "H-type" strap was constructed to hold the catheter 
in position (Fig . 10). The horizontal strap left tHe umbilical stump 
exposed and obviated the use of ligatures. The stump 'Was left open and 
kept dry by spraying the area every 6 hours with methylated spirits. 
Antibiotic creams were not used locally, neither were systemic antibiotics 
(Hodgman, 1971). No heparin was used to avoid blockage as this route was · 
used for intra-arterial fluid infusion by constant infusion pump (Ivac 
Model 501, Ivac Corp.). 
The scalp vein infusion was then discontinued and the position 
of the tip of the arterial catheter localised by portablex-ray. 
Consent 
Informed consent of the parent(s) was obtained for the above 
procedure. 
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Fig. 3 
THE RADIOPAQUE ARI'ERIAL CATHETER IN POSITION 
ABOVE THE DIAPHRAGM IN THE DESCENDING THORACIC AORTA 
we, preferred to locate the tip of the catheter above the diaphragm in the 
descending thoracic aorta (Symansky, 1972) although others prefer to 
position the catheter tip in the abdominal aorta at or above the 
bifurcation (Baker, 1969; Kitterman, 1970). 
As a result of this procedure a chest X-ray could be taken and the 
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presence or absence of hyaline membrane disease .(HMD) was noted. 
Correction of acid-base abnormalities Ya.S routinely performed. 
A sample of arterial blood was withdrawn from the catheter into a 
heparinised syringe, allowing the first 5 drops of blood to be discarded. 
Approximat ely 0,2 ml of heparin (5000 units/ml) wa.s drawn up into a 2 ml . 
syringe , rinsed and the heparin and needle discarded. The pA02 and acid-
base determinations Yere done immediately (Radiometer, Copenhagen) and the 
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r esults calculated f rom the Siggaard-Andersen curve nomogram (Siggaard-
Andersen , 1960 ). Metabolic acidosis was corrected by intravenous 4,Z'/o 
Sodiwn bicarbonate according to the equation: 
mequiv Sodium bicarbonate (ml)= mass (kg) X base excess X 016 
Sodium bicarbonate was used in preference to tris-buffer (THAM) as it 
has no effect on the oxygen dissociation curve and the pH difference across 
the red cell mem~rane (Battaglia, 1967). 
Acid-base estimations were performed daily for the first week 
and bicarbonate corrections done if necessary. After removal of the 
arterial catheter, arterialised capillary blood was collected by heel stab 
for further estimations (Koch and Wendel, 1967). 
Total serum bilirubin estimations were done at the first 
sign of jaundice, and phototherapY (continuous) comm~nced at ·levels 
more than 6 mg/100 ml. Daylight fluorescent bulbs were used, and the bulbs 
changed every 100 operating hours. The eyes were covered with gauze eye pads. 
Phototherapy was discontinued when total serum bilirubin levels fell below 
6 mg/100 ml . 
The trained nursing staff kept a chart of observations which were 
taken at half-hourly intervals. (Fig. 4). 
Fig . 4. 
MONITORING (X)NSOLE SHOWING APNOEA ALARM, CONSTANT 
INFUSION PUMP , OXYGEN ANALYSER AND THERMOMETER. 
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These included incubator temperature, skin temperature, pulse rate, 
respiratory rate, presence of absence of cyanosis, Fi02, periodic breathing 
or asphyxial attacks and vomiting. Dextrostix (Ames) estimations of true · 
blood sugar were done every 3 hours and additional 50% dextrose water added to 
the infusate if the blood sugar level fell below 25 mgm%. 
Apnoea alarm mattresses (Vickers) detected prolonged cessation of 
breathing and alerted the nursing staff. These sensitive instruments proved 
helpful in the detection of marked periodic breathing and apnoeic attacks. 
Antibiotics were not used routinely (Blanc, 1959; Pryles, 1963) 
but were individually given in certain circumstances. _If the gastric 
aspirate (see page 35) showed the presence of more than 5 _pus cells per high 
power field on simple wet preparation or if the culture was positive, 
penicillin and kanamycin in approved doses by intramuscular route vere given 
(Davies, 1972). In some cases where the suspicion of septicaemia was high on 
clinical grounds, antibiotics were given after a blood culture had been per-
formed. Often the clinical suspicion was not confirmed bacteriologically, but 
t his is frequently a problem when managing a critically 111 preterm infant. 
2. ASSESSMENT OF GESTATIONAL AGE 
Between 6 and 24 hours, the gestational age of each infant was 
determined using combined physical and neurological criteria as described by 
Dubowitz et al (Dubowitz, 1970). The scoring was postponed if the infant had 
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a low Apgar score at birth, was asphyxiated or showed signs of severe respiratory 
distress. !~e assessment was made by two independant observers and a 
mean value of the two scores taken. The infant was scored again during 
the successive 4 to 6 days if there was any doubt. The mass and gestational 
age were plotted on an intrauterine growth chart (Lubchenco, 1963). A local 
intrauterine growth chart for Coloured and African infants is available (Malan, 
1967), but few infants with gestational age less than 30 weeks were incorporated 
in its construction. It is, however, very similar in distribution of larger 
preterm and term infants to the Lubchenco chart , so it was .considered safe to 
use the latter in plotting low gestational ages for our population. (Appendix 
Fig.l). 
Wherever possible, accurate "known" maternal dates yere utilised 
in determining gestation age together vith the Dubowitz scoring system, 
and in a fev cases data of gestational age by ultrasonic technique vere also 
available. 
3. SELECTION OF CASES 
Selection of cases to be included in the trial vas made at 24 hours. 
The infant's mass had to be 1500 g or less. All cases Yith clinical and 
radiological evidence of HMD or major congenital abnormalities (e.g. spina 
bifida Yith meningomyelocoele, omphalocoele, congenital cardiac disease, etc.) 
vere excluded. However, ve did include those with be~ign respiratory distress 
and minimal radiological changes Yho no longer had hyperpnoeaat 24 hours. 
Those included in the trial yere allocated into the ORAL or 
PARENTERAL_groups by means of a random selection table. (Appendix, Table IV). 
A total of 86 infants vere studied, 43 in each group. A complete list of 
infants appears in the Appendix, Table V. 
4. THE ORAL GROUP 
The 43 infants in the ORAL group yere managed according to the 
standard nursery feeding routine adopted in the Unit. (Fig. 5). 
For the first 24 hours, 60 ml/kg 10% Invert Sugar Yas infused 
intravenously. On the second day "humanised" full strength milk feeds vere 
introduced and the volume vas increased daily in step-vise manner. The IV 
infusion vas gradually diminished and discontinued on the third day if possible, 
its purpose being to supplement fluid and calorie intake Yhile milk volumes 
yere being increased. 
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Fig. 5 
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Intragastric 11 continuous 11 feeding scheme 
The milk was prepared in the milk kitchen. 
Sterilised 150 ml glass bottles (empty IV fluid bottles) were 
f illed with the required volume for 6 hours feeding. A Pedatrol (Travenol 
Lab.) set, with five 10 ml sachets, connected the bottle to . a nasogastric 
tube and was allowed to fill with milk. A 10 ml sachet was clamped with a 
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pair of artery forceps and allowed to empty over a specific period of 
time at the end of which the following 1o ·m1 was commenced. (See Fig. 6). 
Fig. 6 
NASOGASTRIC FEEDING 
The volume delivered was increased by decreasing the emptying time of 
each sachet. For exaJI1ple: 
10 ml/3 hours = 80 ml/day 
10 ml/2 hours = 120 ml/day 
10 ml/90 mins = 160 ml/day 
10 ml/75 mins = 200 ml/day 
10 ml/ 1 hour = 240 ml/day 
Once the maximum volume of 200 ml/kg/day was attained without 
the infant vomiting (usually about the 5th to 7th day) 11 intormittent 11 3 
hourly milk feeding was possigle. Others have found this method to be 
satisfactory (Smallpiece, 1964). 
2 1 
The Milk 
Although pooled breast milk vould probably have been preferable 
to an artificial milk, the rapid turn-over rate and short patient stay in 
hospital made this impractical. It vas decided to use Nan (Nestle) as a 
substitute because of its similarity to human milk Yi.th particular reference 
to carbohydrate, fat and protein content (Table 1). 
TABLE 1 
% Cal 
CALORIC DISTRIBUTION OF HUMAN MILK AND NAN 
(van der Horst, 1969) 
Human Milk 
Carbohydrate 42 (lactose) 
Fat 50 
Protein 8 
Nan 
I 4!+ (lactose) 
46 
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Nan in full strength dilution supplies 71 cal/100 ml. A 
maximum volume of 200 ml/kg/day therefore supplies 142 cal/kg/day. 
Additional glucose vas added to the milk (4 g/100 ml - an extra 16 cal/100 ml). 
Total daily energy intake vas thus 174 cal/kg/day. 
Vitamin and mineral requirements 
Provided that approximately 450. ml Nan is consumed daily, the 
added vitamins are sufficient to cover normal full-term infant requirements. 
A 1500 g inf ant does not consume more than 300 ml milk daJ ly and the 
proportion of vitamins is consequently insufficent. Additional vitamin 
supplementation is necessary. Daily 01 6 ml Vidaylin drops (Abbott Laboratories) 
vas added to the feed. The combined vitamin content of Nan and Vidaylin drops 
appears in Table 111. (See page 24). 
As 300 ml Nan contains only 1 1 8 mg elemental iron, Ferrodrops 
(Parke Davis) 0 1 3 ml (8 mg elemental iron) vas added daily to the feed. 
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In addition, owing to the small quantity of folic acid in Nan 
(Table III), 1 mg of folic acid yas also added to the feed. Vita.min Ki 1 mg 
yas given by intra.muscular injection at birth only. 
The Yater, mineral and electrolyte content of Nan is given in 
Table II. 
TABLE II 
COMPOSITION OF 'NAN' (Nestle, South Africa, Pty., Ltd.) 
Each 100 ml (normal dilution) contains: 
FAT 
PROTEIN 
LACTOSE 
WATER 
MINERAL 
ELECTROLYTES: 
Sodium 
Potassium 
Calcium 
Phosphorous 
Chloride 
Total 
Electrolytes 
CALORIES 
3,4 g (Butterfat and corn oil) 12,3% essential fatty acid 
1,6 g (Casein/lactalbumin ratio 40/60) , 
7,3 g 
87,4 ml 
0,3 g (Calcium:Phosphorous 0,9:1) 
11 meq/1 
20 meq/1 
13 meq/1 
12 meq/1 
11 meq/1 
67 meq/1 
71 
' I 
Similar vita.min and iron supplements yere given for the first 
year of life to all infants according to their requirements. 
5. THE PARENTERAL GROUP 
The PARENTERAL group yere given nothing by mouth for the first 
10 days. They, hoyever, received 60 ml/kg/day of 10% Invert Sugar on the 
first day. 
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TABLE II I 
TOTAL DAILY VITAMIN CONSUMPTION COMPARED WITH EsrIMATED 
MINIMUM DAILY REQUIREMENTS 
Vitamin E$timated daily Nan . . Vidaylin minimum (300 ml •. ) (o.6 ml) requirements. 
A (IU) 1000-1500 6oO 5000 
I 
C (mg) 30-50 16,2 50 
D (IU) 400-800 129 400 
E (IU) 5-20 +20 
-
- I 
K (mg) 1,5 mg . 
- -
Thiamine 0,4 0,15 1.5 (mg ) 
Riboflavin 
o,5-o,6 0,24 1,.2 (mg ) 
Pyridoxine O-i2-0,3 0,39 0,.5 (mg ) 
Pantothenic 
unlmown 0,12 acid (mg) -
Niacin (mg) 6,o 2,4 10 
B 12 ~ug) 1 ,81 
-
Folic acid 0,35 0,07 (mg) -
Total 
given 
daily 
56oO 
66,2 
529 
20 
-
1,65 
1,44 
o,89 
0,12 
12,4 
,81 
0,07 
The estimated minimum daily requirements in the above table were taken 
f rom the Recommended Dietary Allowances, A report of the Food and Nutritional 
Board, Publ. 1146, National Academy of Sciences, National Research Council, 
Washington, 1964 and from those recommended by many authors (Corner, 1960; 
Fomon, 1967, Wilmore and Dudrick, 1968; Nelson, 1969; Babson, 19Jl, Harries, 1971 and Gamsu, 1972). The vitamin content of Nan was obtained by a 
personal communication from Nestle, Ltd., South A.f'r1oa. 
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On the second day (Fig. 7) TPN was commenced, the parenteral 
fluid being diluted with a maintenance fluid (Polyionic_No. 1, in dextrose 
5% m/v; Travenol) on the second and third days. The concentration of the 
TPN fluid was increased daily in stepwise manner to avoid hyperglycaemia, 
glycosuria, hyperosmolality and dehydration ( Driscoll, 1972, Shils, 1972). 
Maximum concentration and volume (150 ml/kg/day) was reached on the 4th day. 
TPN was then maintained until the 10th day, whereafter milk feeds (Nan, Nestle) 
were initiated in the same manner described for the ORAL group. At this 
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stage, the volume of TPN fluid was decreased, mere~y supplementing the oral milk 
feeds as these werEf increased in volume. _ 11Weaning 11 off TPN is important to avoid 
reactionary hyp.oglycaemia (Harries, 1971 a). Full volume oral milk feeding was 
nchievod by th• 14th day. 
The Parenteral fluid 
Selection of the ingredients of the TPN fluid was governed by 
practical consideratiortk. The fluid had to be constituted daily at the 
bedside as the hospital did not possess a laminar flo'W' cabinet. A Nursing 
I 
Sister mixed the fluid on the locker by as strict an aseptic technique as 
possible, using sterile drapes, mask, go'WTl and gloves . To avoid contamination 
very few ingredients were added to the basid commercial solutions. Random 
samples of the infusate were taken for bacteriological culture from time 
to time, ~ut no positive cultures were obtained.) 
Fig . 8 
The administration layout is shown in Fig. 8. 
· TPN INFUSION 
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tmbilical arterial 
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I 
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Apart from the indwelling umbilical arterial catheter, the entire 
system was replaced daily. Infusions of Amigen (Baxter) and Jitralipid (Vitrum) 
were not given simultaneously, (Shils, 1972)as the presence of electrolytes 
may alter the fat emulsion. Intralipid was infused from 9 a.m. to 2 p . m. and 
Amigen/Dextrose from 2 p.m. until 9 a .m. the following day. It must also be 
noted that the Amigen/Dextrose solution was infused through a Buretrol calibrated 
burette (Travenol) which has a filter of 0,4 u pore size and also through a 
Final Filter (Travenol) of equal pore size . Blood, plasma and Intralipid will 
not pass through these filters. Intralipid was thus infused through a Soluset 
(Abbott) in which there is no filter . A sterile needle connected the Intralipid 
line to the rubber bulb distal to the final filter. Whichever line was not 
in use was clamped to avoid mixing. Figs . 9 and 10 show the system in use on an 
infant. 
Figs. 9 and 10. 
The administration of parenteral fluids in progress on an infant. Note "H-type" 
adhesive strap securing the arterial catheter and "Y" connection of polythene 
tubing carrying Amigen/Dextrose and Intralipid distal to the filter . 
27 
Composition of the infusate 
The daily TPN schedule is outlined in Table IV, summarising 
the concentration of constituents, calories achieved, daily volumes and 
the specific intake of carbohydrate, fat and protein. 
TABLE IV 
DAILY PARENTERAL SCHEDULE 
MAXIMUM PARENTERAL VOLUME (ml/kg) CAL/kg INTAKE g/kg 
DAY AMIGEN 5% SUGAR INTRALIPID TOTAL FAT CHO PROT 10% 
1 60 60 25 6 
10% Invert 
2 40 Amigen 10 
40 Polionic 50% Dextrose 20 110 66 2 9 1,6 . 
no. 1 
3 60 Amigen 20 30 130 101 3 14 2,4 20 Polionic 50% Dextrose 
no. 1 
4 80 Amigen 30 40 150 136 4 19 3,2 50% Dextrose 
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Nutritional and metabolic r equirements in TPN 
An analysis of the constituents of the TPN preparation . · 
appears in Table · V. 
TABLE V 
CONSTITUENTS OF TPN PREPARATION 
VOLUME (ml/kg/day) . CALORIES (cal/kg/day) 
A - INTRALIPID 10% 40 44 
B - AMIGEN 5% in DEXTROSE 5% 80 32 
C - 50% DEXTROSE IN WATER 30 60 
TOTAL 150 136 (0,91 cal/ml) 
I 
ADDITIONS : 
Folvite (Lederle)l mg daily 
Multivitamin infusion (Pancebrin, Lilly) 0,3 ml daily 
FINAL INTAKE 
A - FAT 
B - PROTEIN 
C - CARBOHYDRATES 
D - ELECTROLYTES 
AND MINERALS 
Sodium 
Potassium 
.Chloride 
Calcium 
Phosphate 
Magnesium 
per kg/day 
4 g 
3,2 g 
19 g 
2,8 .meq/1 
1,6 meq/1 
1,6 111eq/l 
o,s meq/1 _ 
2,4 meq/1 
0,2 ,meg/1 
' 
. 
INFUSION RATE 
0,8 g/hr over 5 hrs. 
0~17 g/hr over 19 hrs 
1,0 g/hr over 19 ·hrs 
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The composition of Amigen 5% in 5% ·Dextrose w~ter w/v arid Intralipid 
10% appears in Tabl e VI. 
TABLE VI 
COMPOSITION OF AMIGEN 5% in 5% DEXTROSE WATER Code : M64 
Calories 
pH 5,5 
Dextrose 5% 
340 cal/1 
ESSENTIAL AMINO ACIDS 
Leucine 
Valine 
Lysine 
Isoleucine 
Phenylalanine 
Arginine 
Threonine 
Methionine 
Histidine 
9,1% 
5-,3% 
5,1% 
4,9% 
3-,9% 
3,2% 
2,9% 
2,6% 
1-,% 
Tryptophan 
APPROXIMATE ANALYSIS 
Total nitrogen 13% 
Potential amino acid nitrogen 10,5% 
Amino acid nitrogen 7,8% 
Minerals (ash) 5,5% 
Moisture 4,~ 
ELECTROLYTES AND MINERALS 
Sodium 35 mequiv/1 
Potassium 19 mequiv/1 
Chloride .20 mequiv/1 
Calcium 5 mequiv/1 
Phosphate 30 mequiv/1 
Magnesium 2 mequiv/1 
Baxter Laboratories. 
NON-ESSENTIAL AMINO ACIDS 
Glutamic acid 
Proline 
Serine 
Aspartic acid 
Alanine 
Hydroxyproline 
I 
Glycine 
Oystine 
Tyrosin 
17,1% 
6,.2% 
4,9% 
4,7% 
·4,2% 
1,5% 
o,4% 
o,3% 
·2,~ 
3 0 " 
l 
Glucose vas infused at 1 g/kg/hr (Table VIII) ltlthout hyperglycaemia 
or significant glycosuria. 
We infused 3,2 g/kg/day, vhich approximated the protein intake 
of the ORAL group. 
The provision of linoleic acid in the infusate obviates the syndrome of 
essential fatty ·acid deficiency induced by fat-free intravenous feeding vhich 
has been reported (Paulsrud, 1972). 
Table VII compares the estimated IV requirements as proposed by 
Heird (Heird, 1972) 'With Pancebrin. 
The composition of minerals and electrolytes used· in the solution 
has been shown in Table V. As TPN vas only performed for 10 days, trace 
elements, by means of plasma infusions, -were not given. 
---··-------·----- ·---
~LE VII 
DAILY MULTIVITAMIN INFUSION 
Vitamin Heird (1972) Pancebrin (0.3 ml) 
A 10-200 I.u. 1500 I.u. 
Thiamine 0,2 mg/1000 cal 1,5 mg 
Riboflavin 0,3 mg/1000 cal. 0,3 mg 
Pyridoxine 9 pg/ g protein 0,45 mg 
C 10 mg 9 mg 
D 100-200 I.u. 150 I.u. 
E 0,34-0,45 mg 0,3 mg (unknown) 
Pantothenate unknown 0,45 mg 
Niacin 4,4 mg/1000 cal 3,0 mg 
. 
Folic acid 5-50 )lg 
- * 
Bl2 less than 1 pg 
- ** 
* Given as Folvite (Lederle) 1 mg daily IV 
** Given as Cytamen ( Glaxo-Allenburys) 10 pg weekly IM 
3 1 
In summary , the comparison of the nutrient solutions fed to the 
ORAL and PARENTERAL groups is shown in Table VIII. The additional sugar added 
t o the oral feed is not shown. 
TABJ..E VIII 
NUTRIENT 
ORAL 
NAN (Nestle) 
VOLUME 200 ml/kg 
CARBOHYDRATE 14,6 g 
PROTEIN .3,2 g 
FAT 6,8 g 
WATER 175 ml 
CALORIES 142 cal 
MINERALS o,6 g 
VITAMINS A,B,C,D,E 
6. PARAMEl'ERS STUDIED 
(a). Physical 
SOLUTIONS 
PARENTERAL 
AMIGEN /DEXTROSE/ INTRALIPID 
150 ml/kg 
19 g I I 
3,2 g 
4,0 g 
122 ml 
136 cal 
0,275 g 
A,B,C,D,E 
. 
The infant's mass was recorded ·daily throughout his stay in 
hospital (approximately 6 weeks). The same scale was used for all infants 
(as described on page 1.3). As both feeding schedules were "continuous 11 
no ti.me, r elationship to feeds was necessary. They were weighed at 8 a.m. 
daily. 
.3 2 
Head circumference, taking the largest circumference (occipito-
bregmatic) was measured by one person at weekly intervals using the same 
tape measure , for 6 weeks. 
Length was also measured at weekly intervals. Because of the 
inaccessibility of the patient in an incubator, \10 used a simple method of 
straight ening the trunk and lower limbs with one hand and marking the position 
of the crown and the soles with a ball-point' pen on the mattress. The distance 
between these points was measured in centimetres. Although relatively crude, 
repeat measurements were within 0,20 cm. of each other on the majority of 
occasions. 
Serial mass, length and head circumference were recorded on the 
Lubchenco intrauterine growth charts (Appendix, Fig. 1). 
(b) Biochemical 
(i) Blood 
The study of biochemical parameters was limited by the fact that 
large volumes of blood cannot be freque~tly withdrawn from infants of this 
size . One had to bear in mind that the blood volume of a 1 kg infant is 
only approximately 80 ml. 
Three heparinised capillary tubes (Radiometer, Copenhagen) are 
necessary for acid-base estimations. One heparinised capillary tube was 
used for the total bilirubin estimation. ~One lambda capillary tube was 
placed in Coulter diluent for estimation of the haemoglobin, white cell count 
and haematocrit on the Coulter counter. One capillary tube of blood was 
mixed with 3 similar t ubes of reticulocy-te diluting fluid for the reticulocyte 
count . 
Blood sugar levels were checked by the glucose oxidase method 
f or true blood glucose (Appendix, Table VI) if routine Dextrostix (Ames) 
readings were elevated. The Dextrostix readings were found to be reliable 
provided that the stipulated precautions were taken, i.e. reading exactly 
at one timed minute and washing the blood off the paper gently with a stream 
of water from a wash bottle. Dextros~;ix re~dings require~ one drop of blood. 
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Immunoglobulin M (IgM ) readings required 1 ml of bl ood on the first 
day and were done in the biochemistry laboratory as part of a routine service. 
One ml of blood was taken at birth, 10 days and JO days for estimation of the 
plasma amino acids. The technique will be discussed in Chapterv. 
The Department of Chemical Pathology set up a microtechnique 
service, run by a senior technologist and two assistants who were responsible 
f or more than 5000 individual manual estimations. On 2,0 ml of blood it was 
possible to estimate serum sodium, potassiuin, . chloride, blood urea, calcium, 
phosphate, serum chole sterol, serum glutamic · oxaloacetic transaminase (SGOT), 
total protein, albumin , globulin and osmolality. The tests used were standard 
laboratory methods employed for routine service scaled down where possible 
f or microtechnique purposes. Whenever possible, the tests ·were performed 
in duplicate and a fresh daily standard was used. Details of the tests 
and instruments appear in Appendix, Table VI. 
Technique of taking blood samples 
1. After insertion of the umbilical arterial catheter, blood specimens 
for the first day were taken by this route, using a 5 ml plastic disposable 
syringe previously rinsed with 0 71 ml Heparin (5000 units in 1 ml) which 
was discarded. 
2. Specimens to be collected by capillary tube were obtained from stabs on 
the medial aspect of a heel with a lancet. 
3. After commencement of the TPN schedule, no further samples were taken from 
the umbilical arterial catheter. Blood was obtained by puncture of the 
posterior fontanelle. The hair over the posterior fontanelle was shaved 
and the skin cleaned with hibitane in ' alcohol. A scalp vein infusion 
set was attached to a 5 ml syringe. Using a non-touch technique, the 
needle, held perpendicularly to the skin, was advanced while applying a 
slight vacuum to the syringe to detect entry into the fontanelle. After 
withdrawing the needle, a sterile swab was held over the puncture site 
f or approximately one minute. Persistent bleeding was not encountered, 
and no clinical complications were encountered throughout the trial with 
this technique. It is technically simple and specimens were rarely 
haemolysed. 
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(ii) Urine 
Urine was collected daily for 10 days by means of a polythene 
disposable urine bag (Chironseal). Approximately 5 ml sufficed for Clinitest 
(Ames) testing for urinary sugar (done in the Unit) and for urinary 
electrolytes, urea, creatinine and osmolality which were estimated by the 
routine laboratory. Twenty four hour specimens of urine were difficult to 
collect due to frequent dislodgment of the oae and the fact that the fragile 
skin of infants of low gestational age becomes rapidly excoriated after 24 
hours of continuous collection. For these reasons small quantities of 
urine were collected and the bag immediately removed. 
(c) Bacteriology 
In order to define the infective environment of these infants, 
bacteriological swabs from multiple sites were taken immediately after birth. 
(i) Cord and Ear Swabs were taken after dipping the sterile swab 
into a vial of sterile saline. Early detection of neonatal sepsis is 
assisted by examination of liquid obtained from the external auditory canal 
(Scanlon, 1971). In the laboratory a Gram stain was made and the S'WB.bs 
cultured. 
(ii) The first specimen of Meconium was sent for culture. 
(iii) Within 4 hours of birth 1 70 ml of blood was inserted into 
a blood culture bottle (thiocyanate medium) kept at 37°c and sent for 
culture. 
(iv)~ nasogastric polythene tube (8 Fr., Argyll) was passed 
according to the technique described by ford (Ford, 1967). The distance 
from the nostrils to the catheter tip in the sttimach is tvice the 
length of the sternum (including the xiphisternum) plus 2,5 cm. A gastric 
aspirate was taken for routine wet smear screening for pus cells and also 
for culture. The gastric aspirate after birth contains swallowed amniotic 
fluid and provides an early clue to the presence of an infected intrauterine 
environment (Blanc, 1953 , and 1959). 
(v) Where possible, the placenta was collected and histologic 
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examination of the membranes, cord and placenta performed. Out of 86 
infants, 13 placentas were not collected because the mothers were of the 
Moslem faith. 
The placenta,s were placed in Bouin I s fluid for 24 hours before 
being prepared for histology. 
(vi) While TPN was in progress, a blood culture from a peripheral 
site was taken every 3 to 5 days depending on.the clinical state of the 
infant. In either group, a blood culture was taken when a clinical diagnosis 
of septicaemia was considered. 
(d) Collection of soecimens 
The growth variables and metabolic variables (blo·od and urine) 
were recorded on a serial infant monitoring chart (Fig. 11). With as many 
as four infants being studied simultaneously, this was a helpful means of 
I 
I 
checking the infant's progress and keeping ~ecords intact. 
The blood samples were all taken at 9 a.m. In the PARENTERAL 
group the samples were taken after the 19 hour run of Amigen/Dextrose 
solution and before the commencement of the Intralipid infusion. There 
was no specific relation to feeding in the ORAL group as the milk feeds 
were continuously infused. 
The monitoring chart was strictly adhered to except when the 
day of collection fell on a Sunday, when the test had to be postponed 
24 hours. This only applied to the serum and urine biochemistry. 
The monitoring chart is similar to that proposed by Heird (Heird, 
1972) . 
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Fi g . 11. 
SERIAL I NFANT MONITORING CHART 
SERIAL INFANT MONITORING CHART 
D/,.Y 
QROWTH VARIAJILES 
MASS 
HEIGHT 
HEAD CIRCUMFERENCE 
HETA!OLI C V.ARIABLf:S 
A - BLOO]) 
Sodiu111 
Pot;issiu111 
Chloride 
Ure 11. 
CJ\lcium 
l'hospbate 
Cholesterol 
S.~.O.T 
Total. Protein 
Albumin 
IJlobulin 
Osmol,ili ty 
pH/ 11.cid-base 
.Full blood count 
:l.eticulocytss 
pA02 (11.t birth) 
·i'ot:1.1 bili rubin 
Amino acids 
I ~N 
l 2 3 ~ 5 6 7 8 9 lO 14 21 28 30 42. 
Dextrostix ( AIDes) ....,.....,...,..,,..,...._ ..... ;;;;...;;.;..;..... ... _. _____ _. 
B - UIUHE 
Sodium 
Pot;issiu111 
Chloride 
Urea 
Cre;itinine 
Os111ol11.li ty 
01,initest ( Allies 
The shaded areas indicate the day(s) on which the various parameters were 
studied in each infant. 
(e) EHer'gy Assessment 
The daily energy intake for each infant was calculated by determining 
the exact volume of feed that had been administred over the previous 24 hour 
period . The constituents of the feed for each day were ordered on a fluid 
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intake - calorie balance chart (Fig . 12). 
Fi g. 12. 
DAILY FLUI D BALAN CE - CALORIE I NTAKE CHART 
DAY I 2 3 4 5 6 7 8 9 10 II . 12 13 14 15 16 17 18 
WT (G) 
ORAL 
FEED(MI) 
DEXTROSE 
OR 
INVERT 
AMIGEN 
.. 
POLYIONIC 
NO I 
I 
INTRALIPID 
(Ml) 
TOTAL VOL 
(M) 
TOTAL CAL 
REQUIRED 
CAL 
EXCESS 
DEFICIT 
DAILY WEIGHT, VOLUME ANO CAI.ORIE INTAKE 
In t his way, a record of the daily calorie intake and fluid 
volume was kept for the first 18 days. The required total calories for 
the daily weight was also calculated, as well as the actual daily intake 
of calories achieved. 
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7. SUMMARY 
A. Eighty- six infants of birth mass less than 1500 g, born at 
Peninsula Maternity and Groote Schuur Maternity hospitals, who showed 
no evidence of clinical illness within the first 24 hours after birth 
were included in this study. 
B. The gestati.onal age -was determined by the Dubowitz scoring method. 
The infants 1.1ere allocated to an ORAL or· PARENTERAL group by random 
selection. Umbilical arterial catheters were inserted to lie in 
the descending thoracic aorta. 
C. The ORAL group were fed with humanised milk by continuous intragastric 
drip until a maximum volume of 200 ml/kg/day and maximum energy intake 
of 142 cal/kg/day was achieved. 
D. The PARENTERAL group received feeding exclusively via the umbilical 
arterial catheter by constant ini'usion. A parenteral fluid solution 
consisting of casein hydrolysate, dextrose and fat emulsion provided 
136 cal/kg/day at a maximum volume of 150 ml/kg/day. The parenteral 
infusion continued for 10 days whereafter continuous nasogastric 
humanised milk feeds were introduced. 
E. The management of both groups after 10 days was identical. Physical, 
biochemical and bacteriological parameters were studied at frequent 
intervals from birth to 6 weeks. All results were recorded on a aerial 
infant monitoring chart. 
F. Daily calculation of energy actually supplied was compared with the 
assessment of energy required. 
G. The infective environment of all babies was studied, and the type of 
method of routine nursery care provided for each group was standardised. 
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CHAPI'ER III 
I RESULTS 
1. General Mortality and Mor~idity. 
2. Growth and Energy Assessment. 
3. Haematology and biochemistry. 
4. The Perinatal Infective Environment. 
PART 1 
GENERAL MORTALITY AND MORBIDITY 
(a) MASS , MORTALITY AND SEX INCIDENCE 
(b) GESTATIONAL AGE 
(c) PERINATA1 FACTORS 
(d) CLINICAL COMPLICATIONS 
(e) COMMENT 
(f) SUMYiARY 
(i) · The Apgar Score 
(ii) Intubation 
I 
(iii) The Denver Death Model 
(i) Morbidity 
(ii) Apnoea 
(iii) Vomiting 
GENERAL MORTALITY AND MORBIDITY 
(a) MASS , SEX INCIDENCE AND MORTALITY 
There were 43 infants in each group, 22 males and 21 females. 
The distribution of mass is shown in Table IX. 
TABLE IX 
DISTRIBUTION OF MASS. 
No. Mean Mass SD Range 
Total 86 1264.53 g 22,37 550-1500 g 
ORAL 43 1235.58 g 35,91 550-1500 g 
PARENTERAL 43 1293.49 g 26,39 700-1500 g 
SD= Standard deviation. 
There was no statistically significant difference in birth mass between 
the two groups . (p) .05) 
Distribution in mass groups 
Table X · shows the distribution of infants in mass groups • 
. TABLE X 
DISTRIBUTION IN MASS GRDUPS 
:VJ.ASS ORAL PARENTERAL 
0-1000 g 8 4 
1001-1250 g 13 13 
1251-1500 g 22 26 
TOTAL 43 43 
There was no difference in the distribution in mass groups between the 
ORAL arid PARENTERAL groups. (p),05) 
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MORTALITY 
Only the mortality during the first post-natal month will be 
discussed. The mortality rate for the total, ORAL and PARENTERAL groups 
appears in Table :XI 
TABLE XI 
MOITTALITY 
GROUP No. ALIVE No. DIED % MORTALITY 
TOTAL 71 15 17,4 
ORAL 37 6 14,0 
PARENTERAL 34 9 20,9 
There was no statistically significant_difference in mortality between 
the ORAL and PARENTERAL groups. (p) ,05) 
Mortality in mass groups 
The mortality in each mass category for the two groups is shovn 
in Table XII. 
TABLE XII 
MORTALITY BY MASS CATFiGORY 
MASS CATF.GORY ORAL PARENTERAL TOTAL ~ MORTALITY 
alive died alive died alive died 
1000 g 4 4 2 2 6 6 50% 
1001-1250 g 12 1 7 6 19 7 27% 
1251-1500 g 21 1 25 1 46 2 4% 
Wit~ de.creasing bi1:th mass there was a corresponding increase in 
mortality. The highest incidence of deaths occurred in the PARENTERAL 
group (1001-1250 g). For the overall distribution in mortality there was 
no significant difference between the two groups. 
, 4 1 
Sex incidence and mortality 
There was an equal distribution of males and females in each 
group 22 males and 21 females. 
When considering the mortality rate in either group for males 
and for females, no significant difference could be detected. 
Eight of 42 female and seven of 44 male infants died, representing 
no s i gnificant s.ex difference. ( Table XII!). 
TABLE 'XIII 
SEX AND DISTRIBUTION Oi- ;.:.,.d'1:n£ITY 
NO. DIED % 
I 
(TOTAL 42 8 19 ( 
FEMALES(ORAL 21 3 14 ( 
(PARENTERAL 21 5 23,8 
(TOTAL 44 7' 16 ( 
MALES (ORAL 22 3 14 ( 
(PARENTERAL 22 4 18,5 
(b) GESTATIONAL AGE 
The gestational ages of the 86 inftnts plotted against their birth 
mass are shown in Fig . 13, using the Lubchenco intrauterine growth chart. 
Fig. 13. 
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Distribution of gestational age for each group is sho\lll in Table XIV. 
TABLE XIV 
DisrRIBUTION OF GESTATIONAL AGE 
No. Mean G.A. (wks). SD (Wks.) Range ( wks. ) 
TOTAL 86 30,81 0,22 26-36 
ORAL 43 30,78 o.,35 26-36 
PARENTERAL 43 30,84 0,29 26-34 
SD= Standard deviation of the mean 
.. 
•0 
•P 
There was no significant difference in gestational age between 
the tuo groups. (p ) ,05) 
• ••• .> 
.. 
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Assessment of intrauterine ~rowth at birth 
Of 86 infants, 72 were appropriate for gestational age (AGA) 
and 14 were small for gestational age (SGA) being above or below the 10th 
percentile of mass for g·estational age respectively. 
There were 9 SGA infants in the ORAL group- and ·5 in .the PARENTERAL 
group. This difference was not significant (p ) . ,05). 
The total incidence of SGA inf ants was therefore 16% • 
Validity of gestational age assessment 
' . 
In order to assess the validity of the Dubowitz method of 
determining gestational age, the length of term of gestation where the mother 
gave an actual date for the last menstrual period was plotted against the 
score obtained in 52 infants. 
A linear regression line with a correlation of r = 01 915 
{y = 1110x - 2,88) was obtained, which compared satisfactorily with that 
obtained by Dubowitz (1970). 
This indicates that the Dubowitz scoring method is applicable 
to infants of vezry low birth mass in the Coloured and African populations 
studied. 
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MORTALITY BY GEsrATIONAL AGE 
The gestational age of the infant was more important than the 
mass in determining the chance of survival. 
Fourteen of the 15 deaths were ·in babies with a gestational 
age or · less than 30 weeks . The 15th death occurred in a baby whose gestational 
age was assessed to be between 30 and 32 weeks . No others died. 
The distribution of gestational ag~ against mortality for the 
two groups is shown in Table XV. 
TABLE XV 
GESTATIONAL AGE DisrRIBUTION AGAINST MORTALITY 
GESTATIONAL AGE ORAL PARENTERAL TOTAL % MORTAL-(weeks) ITY 
alive dead alive dead alive dead 
4- 27.9 1 4 0 1 1 / 5 83,3 -
28.0-29.9 7 1 5 8 12 9 42,8 
30.0-31.9 17 1 13 0 30 1 
· 3,3 
32.0-33.9 7 0 13 0 20 0 
-
34.0-35.9 4 0 3 0 7 0 
-
> 36.0 1 0 0 0 1 0 
--
37 6 34 9 71 15 17,4 
There was no significant statistical difference in the distribution 
for gestational age between the two groups. 
The above table shows even more clearly than birth mass that 
mortality is directly related to decreasing length of gestation. 
The high incidence of deaths in the PARENTERAL group with birth 
mass from 1001-1250 g is attributable to the fact that these infants were 
appropriate for gestational age and between 28,0 and 29,9 weeks gestation, 
whereas the infants in the ORAL group with birth mass from 1001-1250 g were 
between 30,0 and 31,9 weeks gestation. (See Appendix, Table VII). 
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(c) PERINATAL FACTORS 
(i) THE APGAR SCORE 
A st atistical comparison of each individual Apgar score for the 
two groups was not possible. 
When the Apgar score was arbitrarily divided into two categories, 
viz: 1-5 (poor) and 6-10 (good), a relationship between score and mortality 
was observed. Table XVI shows the distribution of Apgar scores and 
mortality at l minute and 5 minutes. 
TABLE XVI 
APGAR SCORE AND MORTALITY 
1 MINUTE 5 MINUTES 
SCORE alive dead % mort. alive dead % mort. 
, 
< 5 18 8 30,1 8 3 27,3 (poor) 
> 5 (good) 53 7 11,6 63 12 16,0 
TOTAL 71 15 17,4 71 15 17.,Li-
(p <,05) There is a statistically significant difference in mortality 
between those infants with a poor score at 1 and 5 minutes and those with 
a good score, i.e. a poor score is associated with a higher mortality 
rate. This difference is more marked at 1 minute than 5 minutes. 
(ii) INTUBATION 
Endotracheal intubation was performed as a resuscitation procedure 
in 12 of the 86 infants. This was indicated if the infant "Was asphyxiated at 
birth, failed to establish spontaneous respiration by 3 minutes, or the pulse 
rate fell below 80 beats/minute. 
The mortality rate for infants not requring intubation at birth was 
15,0% (11/74) compared \.Tith 33,3% (4/12) for those that were intubated. This 
was a significant difference (p < ,05). 
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(iii) THE DENVER DEATH MODEL SCORE 
The Denver Death Model (Appendix, Table VIII) is a predictive 
scoring system devised to predict the expected mortality rate of an infant, 
t aking into consideration mass, gestational age, Apgar score and maternal 
antenatal factors. 
The Model ..ra.s calculated for each :µifant. 2 Ax Goodness of Fit 
. 2 t est vas performed for this data. It turned out ax = 6,44 Yi.th 7 degrees 
2 . of freedom for the PARENTERAL group and ax = 10,54 Yi.th 7 degrees of 
f reedom for the ORAL group. Thus the model did not fit the data for the 
ORAL or PARENTERAL groups. · 
The reason for this is probably that the 86 infants were selected, 
i .e. asphyxiated infants and those Yi.th hyaline membrane disease were 
excluded . The influence of intensive care may also have altered the predictive 
I 
mortalit y for the group. 
The distribution of Denver Death Scores is tabulated in Appendix, 
Table IX. 
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(d) CLINICAL COMPLICATIONS 
(i) MORBIDITY 
Despite the reduction in neonatal mortality in this study, the 
neonatal morbidity rate remained-high, and was a constant problem in the -
management of these infants. Of the 86 infants, only 38 reached the end 
of the first post-natal growth month without complications or the need for 
antibiotics. The remaining 48 infants had complicated clinical courses. 
, 
Table XVII shows the incidence and distribut~on· of complications and cause 
o.f death for the two groups. 
TABLE XVII 
CLINICAL COMPLICATIONS 
COMPLICATION ORAL PARENTERAL TOTAL 
alive died alive died alive died 
I 
None 22 0 16 0 38 0 
Pneumonia 5 1 3 2 8 3 
,> 
Septicaemia 4 1 3 1 7 2 
Enteritis 1 1 3 0 4 1 
Catheter 0 0 4 0 4 0 
Recurrent 5 2 5 3 10 5 apnoea 
Intracranial 0 1 0 2 0 3 haemorrhage 
Unexplained 0 0 0 1 0 1 death 
37 6 34 9 71 15 
There "18.S no significant statistical difference in complications 
between the ORAL and PARENTERAL groups. (x2 = ,0472 with Yates correction). 
There were no deaths among the 38 infants who had no complications. Of 
the 48 infants who had complications, 15 died. The cause of death was 
determined by post-mortem examination in 10 pf the 15 infants. 
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Recurrent apnoea was a t'erm used in ·this study to denote those 
infants who stopped breathing for prolonged periods wi~h accompanying change 
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in skin colour and bradycardia for which no cause could be found, either ~linical, 
infective or metabolic. This subject will be discussed at a later stage. 
One third of these infants (5/15) died. All 5 were extremely immature 
(-26-29 weeks). Their poorly functioning respiratory centresp (Miller, 1959) 
may have been a contributory factor. 
Septicaemia uas diagnosed only on re~eipt of a positive blood 
culture from a peripheral site other than the arterial catheter. Despite 
the longer period of placement of the catheter in the PARENTERAL group, 4 
positive blood cultures were obtained compared with 5 in the ORAL group. 
The diagnosis of pneumonia was made in 11 infants. The clinical 
signs of pneumonia were often not obvious, and in the majority the illness 
was manifested by the onset of apnoea and then confirmed by roentgenogram. 
In 3 patients the pneumonia was extensive at the time of diagnosis and they 
died shortly afterwards. 
The term "enteritis" includes gastroenteritis and necrotising 
enterocolitis. There were two cases of necrotising enterocolitis, one in 
each group. The infant receiving TPN survived. One infant had Specific 
E. Coli Type 0111 gastroenteritis, but no organism \18.S identified in the others. 
All 3 infants with gastroenteritis survived. 
Three infants died after an intracranial haemorrhage. All were 
of low gestational age (27 to 28 74 weeks) and had received Vitamin Ki at 
birth. Coagulation studies were not done. 
There uas one unexplained death, which occurred at night when the 
unit was short staffed. The infant had previously been clinically well and 
had been receiving TPN for 10 days. There had been no metabolic abnormality 
(acid-base and electrolytes) 12 hours previously and the infant was not 
receiving oxygen. The apnoea mattress had been removed. No pathological 
cause could be found at post-mortem. 
Catheter complications occurred only in the PARENTERAL group. 
In 4 infants the sudden development of blue toes necessitated \.li.thdrawal 
of the cathet ers (between the 5th and 10th day). In none of these infants 
was there disappearance of pulses in the affected limb. The toes became pink 
after removal of the catheter. TPN was continued by peripheral vein through 
a scalp vein infusion set. 
(ii) APNOEA 
An apnoeic attack "1as defined as ce·ssation of breathing for more 
than JO seconds accompanied by a change in skin colour and bradycardia 
(less than 100 beats per minute). 
In t his study the incidence of apnoeic attacks is shown in Table 
XVIJil . 
TABLE XVIII 
NO APNOEA -
.-APNOEA 
I NCIDENCE OF APNOEIC ATTACKS (TOTAL AND GROUPS) 
FIRST 10 DAYS NEXT 20 DAYS No. of infants No. of infants 
ORAL PARENTERAL TOTAI % ORAL PARENTERAL TOTAL 
28 26 54 62,8 33 36 69 
15 17 32 37,2 10 7 17 
43 43 86 43 43 86 
% 
80,2 
19,8 
There was no statistically significant difference in the incidence 
of apnoea between the ORAL and PARENTERAL groups either during the first 10 
days or during the next 20 days. 
The incidence of apnoea was higher (37,2%) during the first 10 
days t han during the next 20 days (19,8%). 
Annoea r elated to mortality 
(a ) First 10 days 
During t he f irst 10 days of life, apnoea occurred in 14/15 
infants who di ed compared \.Ii.th 18/71 infants who survived. · This is a 
statistically significant difference (p < ,001). 
13 of the 15 deaths occurred \.Ii.thin 10 days of birth. 
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(b) Next 20 days 
During the next 20 days of life, apnoea occurred in 2/15 infant s 
who di ed and 15/71 infants who survived. This is not a significant 
differ ence (p ),05) suggesting that mortality is not related to apnoea 
occurring af ter 10 days. 
Two of the 15 deaths occurred between 10 and 30 days (Case No. 61 
. . 
with necrotising entercolitis and Case No. 'l7 'With pneumonia). Both had . 
preceding apnoea. 
The frequency of apnoeic attacks for all infants appears in 
Appendix, Table X. 
(iii) VOMITING 
Despite care in the placement of the nasogastric feeding tubes, 
· ther e was still a high incidence of vomiting, particularly in the ORAL 
group . 
There was naturally a statistically significant difference in 
vomiting i n the fir st 10 days between the ORAL and PARENTERAL groups, as 
the l atter group were not fed by nasogastric route. In the ORAL group 
31/43 (7Z'/o ) i nfants vomited compared with 12/43 (28%) infants in the 
PARENTERAL group. 
Vomit ing was frequen~ly associated with clinical illness, which 
a~ounts for t he vomit·ing in tbQ· PARENTERAL group. 
Correlation between apnoea and vomiting vas not statistically 
valid due to small sample size, but the frequency of the incidence for both 
in the same infant . seemed to be associated. (See Appendix, Table XI). 
5 1 
(e) COMMENT 
Intensive care nursing has reduced the neonatal mortality rates 
of low bir th mass infants. In infants weighing less than 1000 g at birth; 
Alden reported a mortality of 86,4% (Alden, 1972) and Washington 81,1% 
(Washington, 1970) . In Alden's series of 161 infants, 66% had hyaline 
membrane disease and 5% survived. 
The impact of intensive care is better seen in infants with birth 
mass between 1000 and 1500 g. Mortality rates from various centres vary 
f rom 18% (Kitchen, 1971) to 30,5% (Washington, 1970) and the improvement 
is attributed to careful O?CYgen monitoring, early IV glucose and correction 
of acidosis. 
The mortality rate in this study shows a considerable 
decrease from that of the previous year mortality rate (63%) in the same 
nurseries and can be attributed to the same factors. If the infants excluded 
f rom the study (asphyxia and hyaline membrane disease; page 19) are 
takeh. into consideration, the overall mortality rate is 31,5% which still shows 
a considerable improvement in survival. There was no difference in mortality 
between ORAL and PARENTERAL groups. Bryan (1971) and Subramanyam (1972) in 
similar trials, were unable to demonstrate an increase in mortality in 
infants treated with TPN. 
Carrier (1972) has sho.m. a reduction in neonatal mortality between 
institutions which have and those which do not have intensive care nurseries. 
With the advent of a reliable means of gestational age assessment 
(Battaglia, 1967; Dubowitz, 1970; Lubchenco, 1972 b) a better classification 
of newborn infants than low birth mass alone or mass for gestational age 
was inevitable. This classification identifies those infants needing special 
observation and their mortality risk. 
Saint-Anne Dargassies (1955) observed that neurological maturation 
followed a constant time scale which was unaffected either by the time of 
birth or by variations in body mass. Assessment of gestational age by 
neurological examination was described by Koenigscerger (1966), Robinson (1966) 
a~1d Amiel-Tison (1968), relying on the presence or absence of reflexes in 
relation t o gestational age, and the stage of development of active and passive 
5" 
muscle tone. External criteria were described as an objective method 
for gestational age assessment by Usher (1966). Dubowitz (1970), 
incorporating both external and neurological criteria, proposed a scoring 
system to determine the gestational age of the infant. In her initial 
analysis, very few infants less than 30 weeks gestation were included, and 
it is of interest to note that the gestational age assessments done in 
this study using the Dubowitz scoring system .correlated well with her linear 
regression line. Similar findings for term and larger preterm Coloured 
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and African infants have been obseCTed (Jarosze'Wicz and Boyd (1973) (Singer, Blake 
and Wolfsdorff, 1973). As in this study, Vapaavuori (1970) found a better 
correlation between gestational age and perinatal mortality than birth mass 
and perinatal mortality. 
For any given birth m~ss, there is an improvement in mortality 
rate with longer gestation (Lubchenco, 1970). In this ' study, all 14 infants 
judged small for gestational age (SGA) survived. It would appear that 
intrauterine growth retardation ·below JO weeks gestation is not common 
' 
(See Fig. 13). 
Unlike other sUCTeys (Drillien, 1964; McDonald, 1967), there was 
no difference in incidence nor mortality between the sexes. 
011..r finding that a low Apgar score after birth is associated with 
decreased survival agrees with others (Apgar, 1966; Alden, 1972). 
The primary risk of chronic aortic catheterisation appears to be 
embolisation (Erkan, 1968). The incidence of complications due to aortic 
catheterisation in this study was 4,€:Jo • . 
Complication rates from 3-5% (Kitterman, 1970) and 8% (Peter, 1972) 
to 14% (Hodgman, 1971) and 17% (Symansky, 1972) have been reported. In the 
f our catheters that were withdrawn, partial blockage by blood clot was noted. 
The incidence of catheter complications would seem to be related 
to the duration of catheterisation, as catheters in the PARENTERAL group 
were inserted for approximately 12 days compared with 4 days in the ORAL 
group . In the latter group no complications were noted. 
Apnoeic attacks are common in infants of very low birth mass , vith 
Miller reporting a JO% incidence in infants from 1001-1750 g (Miller, 1959), 
Daily 25% in infants from 765-2552 g (Daily, 1969) and Alden 84% in those 
less than 1000 g (Alden, 1972). 
Mortality is higher in infants vith apnoea than those without, and 
apnoea is commonest in the first 10 days of life. The incidence rises with 
increasing respiratory insufficiency (Miller, 1959) which explains why it 
occurred most frequently in infants less tha.ri JO weeks gestation. 
In a study of apnoea, Daily found that both bradycardia and change 
of skin colour occurred with JO seconds of cessation of breathing (Daily, 
1969) . Although others (Miller, 1959; Reid, 1966) define apnoea as 
cessation of breathing for more than 60 seconds, we decided to accept JD 
seconds for the definition as colour change and bradycardia were present 
by this time. The alarm was triggered after 10 seconds apnoea .and the 
I 
nursing staff were thus able to begin resuscitation by JO seconds. 
On three occasions apnoea was probably induced by excessive skin 
temperature (Cross, 196?) caused by the additional heat provided by the 
bank of fluorescent phototherapy tubes through the incubator perspex. 
Incubator temperature had to be carefully controlled while phototherapy 
was in progress. 
There did not appear to be an association between pH and apnoea, 
but a steady rise in pC02 heralded the onset of apnoea in many cases. 
Resuscitation was prompt and vigorou~ being mindful of the fact 
that repeated bradycardia and hypotension associated with apnoea may result 
in brain injury (Myers, 1972). 
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(f ) Sli'MMARY 
1. There was no significant difference in birth mass, sex incidence, gestational 
age and Apgar scores between the ORAL and PARENTERAL groups. 
2. The overall mortality rate was 17,4%. The mortality rate in the ORAL 
group was 14% while . that of the PARENTERAL group was 20,9"/o, demonstrating 
no statistical~y significant difference between the two groups. 
3. No deaths occurred among infants who were SGA. Mortality was directly 
related to the shortest term of gestation-..~ Only one death occurred 
in an infant of more than 30 weeks gestation. 
4. Good Apgar scores at one minute were related to better survival rates. 
5. The Denver Death Model Score did not predict the possible outcome of the 
infant probably because the group was selective. 
6. Mortality was higher in those infants requiring intubation at birth. 
7 •. Morbidity rates (total 48/86 infants) were high. No difference in 
morbidity between the two groups was seen except for catheter complications 
which occurred exclusively in the PARENTERAL group and were related to 
the duration of catheterisation. 
8. The incidence of apnoea in the first 10 days is associated with increased 
mortality. There also appears to be an association between the frequency 
of vomiting and apnoeic attacks. No significant difference in the incidence 
of apnoeic attacks was observed between the ORAL and PARENTERAL groups. 
9. Even if those infants who were not included in the trial are considered 
together with those who were, the overall mortality rate was reduced 
from 63% (1971) to 31,5% following the' introduction of intensive care 
in this Unit. 
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PART 2 
GROWTH AND ENERGY ASSESSMENT 
(a) POsr-NATAL GROWTH 
(i) Mass 
(ii) Length 
(iii) Head circumference 
(b) DAILY MASS GAIN 
( c) ENERGY srUDIES 
(i) Daily calorie intake 
I 
(ii) Calories required for initial mass gain 
(d) COMMENT 
(e) SUMMARY 
(a) POST- NATAL GROWTH 
The relat ive growth of the infant in mass , head circumference 
and length was documented from birth to six weeks. After 35 weeks gestation 
t he rate of growth of twins differs from that of singletons (Lubchenco~ 
1970). There were 5 pairs of twins in this study. However, their gestational 
ages ranged from 28 to 32 weeks, so their relative rate of growth has, for 
simplicity, been included with the singleton~ in the analysis. 
Separate growth curves have been constructed for . appropriate and 
small for gestation age babie~. The growth curves are plotted against 
the Colorado Intrauterine growth charts for mass, length and head circumference 
(Lubchenco, 1966). See Appendix, Fig. 1. 
There was no significant statistical difference in birth mass or 
gestational age between the ORAL and PARENTERAL infants, neither was there 
any statist ical difference in relative growth rate for the two groups during 
I 
the 6 post-natal weeks. 
The following graphs consequently express the growth rate for the 
total study group. The distribution of mass and gestational age for appropriate 
and small infants is shown in Table ru. 
TABLE XIX. 
DISTRIBUTION OF MASS AND GESTATIONAL AGE (TOTAL GROUP) 
MASS (g) 
mean _SD 
APPROPRIATE + 1264,8 - 24,7 
SMALL 1263 ,2 + 54~3 -
TOTAL 1264,5 + 22,4 
-
SD= standard deviation 
of the mean 
GESTATIONAL AGE ( wks) 
mean SD 
30,3 + 
-
0,2 
33,5 + 0,5 
-
+ 30,8 - 0,2 
n = sample size. 
n 
72 
14 
86 
The small for gestational age group , . while having a similar 
mean birth mass to the appropriate group, had a higher mean gestational age. 
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(i) llilli§ 
The relative growth in mass for the appropriate group (AGA) is 
shoi,m in Fig. 14. 
Fig. 14 
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Starting on the 50th percentile at birth, the mass gain fell to 
the 25th percentile and remained at this level until 6 weeks. 
The relative growth in mass for the small for gestational age 
grou (SGA) is shown in Fig. 15. 
Fig. 15 
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The rate of mass gain remained below the 10th percentile throughout 
the first 6 weeks. Of all three growth parameters, growth in mass was most 
noticably affected. 
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( i.i ) LENGTH 
The relative grouth in length for the AGA infants is shown in Fig . 16. 
Fi g. 16 
The 
(Fig. 14). 
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rate of grouth in length closely approximated rate of mass gain. 
relative grouth in length for the SGA group of infants is 
17. 
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In the SGA group of infants, growth in length vas less affected 
by intrauterine gro'\Jth retardation than mass. Nevertheless, mean values 
for gro'\Jth in length remained persisterfl..y just belov the 10th percentile 
f or the first 6 veeks. 
(iii) HEAD CIRCUMFERENCE 
The rate of increase in head circumference for the AGA infants 
is shown in Fig. 18. 
Fig. 18. 
GROWTH - HEAD CIRCUMFERENCE (AGA) 
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The mean head circumference for this group fell between the 25th 
and 50th percentile at birth and folloved the 25th percentile for the next 6 · 
veeks. Gro'\Jth in mass, length and head circ~erence for the AGA group 
therefore exhibited a similar pattern. 
The rate of increase in head circ~ference for the SGA group 
of infants is shown in Fig. 19. 
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Fig. 19. 
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The mean values for head circumference for this group remained 
below the 10th percentile for 4 weeks, but by 6 weeks the mean value had 
surpassed the 10th percentile. 
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(b) DAILY MASS GAIN 
To facilitate anaylsis of the mean daily mass gain, infants were 
divided into 3 mass categories(< 1000 g, 1001-1250 g and 1251-1500 g). 
The mean daily mass gain in grams in each of the three categories for the 
two groups is shown in Appendix, Table XII. By the 10th day, the daily mass 
gain was higher in the PARENTERAL group in all three mass categories. 
However, this advar;tage was not apparent by 30 days when daily mass gains in 
the< 1000 g and 1001-1250 g categories were similar for the two groups. In 
fact, the daily mass gain from 10-30 days:h the 1251-1500 g group was higher 
in the ORAL group. 
For easier comparison, mass gain during the first 30 days is 
better expressed as percentage gain over birth mass. Figs. 20, 21 and 22 
depict the mean percentage mass gain at 10 and 30 days for the ORAL and 
PARENTERAL groups. 
Fig. 20. 
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In all 3 categories, mass gain was significantly higher in the 
PARENTERAL group at 10 days. There was no significant statistical 
differ ence in mass gain between the two groups by 30 days in the<: 1000 and 
1001-1250 g categories. In the 1251-1500 g category, mass gain was 
significantly higher in the ORAL group (p<,Ol). 
The percentage mass gain for the two groups in each category 
appears in the Appendix, Table XIII. 
I 
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( c ) ENERGY STUDIES 
(i ) Daily calorie intake. 
The precise energy requirements of low birth mass infants are 
not known. An- arbitrary energy requirement of 150 cal/kg/day was selected. 
The actual daily calorie intake for each infant was calculated and expressed 
as a percentage of this energy requirement. The mean ratio of calorie 
intake to required calculated calories expressed as a percentage appears 
in Appendix, Table XIV. 
The daily calorie intake for the ORAL and PARENTERAL groups was 
similar but not identical. The calorie intake from milk for the ORAL group 
was 142 cal/kg/day. In addition dextrose (8 g/200 ml milk) providing 
approximately 32 cal/kg/day was added (see page 14) raisi~g the calorie 
intake to a maximum of 174 cal/kg/day. The maximum calorie intake for the 
PARENTERAL group was 136 cal/kg/day. 
The systematic increase in daily calorie intake paralleled the 
increase in daily fluid intake {see Figs . 5 and 7). 
The daily calorie intake expressed as a percentage of the required 
calculated calorie intake is shown in the 3 mass categories for the ORAL 
and PARENTERAL group in Figs. 23, 24 and 25. 
Fig. 23 
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Fig. 25 
CALORIE INTAKE - 1251-1500 g 
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The mean ratio of calorie intake to required calculated calories 
(expressed as a percentage) is given in Table XIV, Appendix. 
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From the second to the 5th or 6th day the PARENTERAL group 
achieved higher daily calorie intakes, significantly higher in the 1001-1250 
and 1251-1500 g mass categories. 
Between the 5th and 6th days, the calorie intakes of the two 
groups were similar. 
After the 5th or 6th days, the calorie intake in the ORAL group 
in all 3 mass categories was significantly higher than the PARENTERAL group. 
This is expl ained by the fact that maximum volume milk feeds had been 
established by this time. 
(ii) Calories required for initial mass gain 
An estimate was made of the calorie intake required to support 
initial mass gain after birth. 
Table XX indicates the mean day on which mass gain occurred 
after birth. It also indicates the mean ratio of calorie intake to required 
calories expressed as a percentage on the day that mass gain occurred. 
TABLE XX 
% CALORIE INTAKE ON DAY OF INITIAL WEIGHT GAIN 
% (cal. intake/req. cal) Mean day of 
At which mass~gain mass gain MASS 0~ - p 
CATEGORY ORAL PARENTERAL ORAL PARENTERAL 
mean SD mean SD 
< 1000 g + 31,32-8,17 + 36.,06..'..4,92 2 2 p>,05 
1001- + + 6 1250 g 73,70-7,61 77,70-4,58 5 p >~05 
1251 - + + 6 6 1500 g 85,32-3,26 85 .. 77-1,53 P>,05 
SD= Standard deviation of the mean. 
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There was no statistically significant difference between the 
percentage of required calculated calories achieved on the day of initial 
maS3 gain for the ORAL and PARENTERAL groups. 
Mass gain occurred earlier (from the second day) in the ( 1000 g 
category. In the other two categories mass gain occurred between the 5th 
and 6th days . 
The actual energy required for initial mass gain in each mass 
category _is show in Fig. 26. 
Fig. 26 
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~ 1000 g 47 - 54 cal/kg/day. 
1001-1250 g 110 -116 cal/kg/day. 
1251-1500 g 128 -129 cal,/)cg/day. 
These are only crude estimations but serve as a clinical approximation 
of the basic energy required to support initial mass gain (or growth). The 
influence of IV fluid on the daily mass gain cannot be disregarded, although 
accepted daily fluid volume requirements ~ere not exceeded. 
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(d) COMMENT 
Hass, length and head circumference 
The smaller the infant and the shorter the term of gestation, the 
greater is the deviation from intra-uterine growth rate after birth (Lubchenco, 
1970). In a study of low birth mass infants, Babson (1970) observed that none 
of them caught up to the normal growth curves for length, head circumference 
and weight at 1 year, especially those who w~re small for gestational age. 
In this study, the growth curves for all three parameters in 
AGA infants followed the 25th percentile in similar manner, indicating that 
no curve singly was superior to the others as a criterion of growth. In 
other studies, length (Babson, 1969) and head circumference (Parmelee, 1964) 
have been prop~sed as better single criteria of growth than mass. 
In the SGA group, growth in· mass showed a greater deviation from 
the 10th percentile than length and head circumference , although all 
I 
parameters were below this percentile. In quantitative terms, the degree 
of intra-uterine growth retardation in these infants was severe (Lubchenco, 
1970). An interesting finding was the indication of catch-up in head 
circumference (above the 10th percentile) at 6 weeks . This may be an early 
indication of the growth spurt in head circumference seen in preterm infants 
(Babson, 1970). 
The mean daily growth in head circumference for AGA and SGA 
infants was 0,10 cm which is the same rate of growth reported by Davies 
(1970) in 120 similar infants subjected to early feeding. She showed that 
early feeding routines produced a significantly greater rate of head 
growth. This may be important when considering the subsequent neurological 
development of the child as Winick (1969a) has shown a linear relationship 
between total brain DNA content and change in head circumference. It is 
hoped that the early feeding routine practised and the good rate of head 
growth found in the SGA group of infants will also have a beneficial effect 
on their subsequent development. 
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The average daily length gain was 1,24 mm for the first six weeks 
which is similar t o but higher than the 0,97 mm gain reported by Glaser 
(1950) for infants from 1001-1500 g during the first 2 months . The 
difference could possibly be explained by the early feeding routine in 
this study which was not practised 20 years ago. 
There were no significant differences between the ORAL and PARENTERAL 
groups as regards_ rate of growth of head or length. TPN was thus 
not capable of emulating intra-uterine growth -rates for the first 2 weeks. 
Similar findings have been reported by Benda, ~971), Duncan (1972) and Bryan 
(1973). 
Daily mass gain 
The mean daily mass gain for the first 6 weeks was 21,2 g/day 
which compares favourably with results reported by others (Table XXI). 
TABLE XXI 
MEAN DAILY MASS GAIN (LOW BIRTH MASS INFANTS) . 
AUTHOR YEAR MEAN MASS GAIN (g/day) 
Glaser 1950 10,5 
Kagan 1955 8,14 - 11,28 
Levin 1959 13,9 - 16,1 
Goldman 1962 10,9 - 13,2 
Davidson 1967 8,87 - 10,25 
Babson 1969 14,J - 19,6 
PRESENT STUDY 1973 21,2 
The variation in findings for each author depended on whether 'low 
ash" or "high ash11 content milk was used. Nan has an "intermediate ash" 
content. 
During the first 10 days the mean daily mass gain was 2,39 g 
(1001- 1250 g) and 5,43 g (1251-1500 g) for the ORAL group compared with 
5,04 g (1001-1250 g) and 12,95 g (1251-1500 g ) for the PARENTERAL group . 
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After TPN 'W8.S discontinued, this advantage was no longer apparent by 2 
weeks. The mean daily mass gains during TPN compare with the 15 g (700-1700g) 
reported by Peden (1972), 8,5 g (1001-1250 g) to 10 g (1251-1500 g) repor~ed 
by SUbramanyam (1972) and 15.,5 g ( < 1200 g) reported by Driscoll (1972 a). 
Time to regain birth mass and calories required for mas@ ga~n. 
Due to early provision of increasing amounts of calories and 
protein, the time to regain birth· mass in infants from 1001-1500 g was 5 
to 6 days, by which stage the daily calorie intake had reached 110-129 
cal/kg. 
When infants of similar mass received an average daily calorie 
intake of 22 cal/kg for the first week and 80 cal/kg for the second week, 
the time to regain birth mass was 3 to 5 weeks . (Cherry, 1959). Smallpiece 
(1964) showed that late-fed infants took 5 days :bnger to regain their birth 
w~ight (14,5 days). More recently Ghadimi (1971) showed that infants less 
than 1500 g took 10 days to regain birth.mass and 8 days to achieve his 
arbitrary caloric requirement of 120 cal/kg/day. 
More rapid regain of birth mass with TPN in infants less than 
1500 g has been reported. In Bryan's study (Bryan, 1971) those receiving 
supplemental intravenous alimentation regained birth mass by 14 days 
compared with controls (22 days) . In Driscoll's study (Driscoll, 1972), 
infants receiving TPN regained birth mass by 11,4 days compared with 
controls (18,2 days). No difference was noted in this study. 
Calorie intake 
Heird (1972) has estimated that the minimal metabolic requirement 
of a small preterm infant (1000 g) with allowance for cold stress and activity 
during semistarvation is from 50-75 cal/kg. A fall in the Respiratory 
Quotient (which indicates relative starvation) can be prevented by administration 
of 60-80 cal/kg/day during first week (Krauss, 1969). Holt (1959) found that 
130 cal/kg/day supported a good growth rate in preterm infants. Babson (1971) 
advises 110-140 cal/kg/day. From the rough estimations in Fig. 26, it would 
appear that 110-130 cal/kg/day would be sufficient to support growth. 
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It is difficult to draw conclusions about the caloric requirements 
of the infants with birth mass less than 1000 gin this study. Although 
the caloric intake was greater in the ORAL group from the 7th to the 10th 
days, the percentage mass gain was much higher in the PARENTERAL group. This 
lead. one to suspect that a proportion of the mass gain was due to extra-
cellular fluid accumulation. Although preterm infants have been fed oral 
fluid volumes of 250 ml (Gamsu, 1972) to 350 ml/kg/day (Keitel, 1959) 
without evidence of increase in the extracellular fluid, it is possible 
that an IV volume of 150 ml/kg on the 5th day in an infant of extreme low 
birth mass may exceed the ability of the kidneys to excrete excess water 
and electrolyte. An I.V fluid volume (maximum) by the end of the first 
week of 100-120 ml/kg/day (Bruck, 1972; Fanaroff, 1972) is probably closer 
to the correct requirement . (Note: the daily IV fluid volume in the 
intensive care nursery for preterm infants has been reduced to a maximum 
of 120 ml/kg/day). Statistical calculations were not aone in this mass 
category because of the small sample size. (Appendix, Table XII). 
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(e) SUMMARY 
1. There was no significant difference in the rate of grovth over the first 
6 weeks between the ORAL and PARENTERAL groups judged by mass, length 
and head circumference. 
2. The grovth curve for AGA infants followed the 25th percentile. No single 
parameter was superior to the others as a . criterion of the rate of 
grovth. Post-natal grovth was slower than 'intra-uterine grovth. 
3. In SGA infants, all three parameters were below the 10th percentile. 
Head grovth showed signs of catching up at 6 weeks when it crossed over 
the 10th percentile . 
4. The daily rate of grovth in head circumference was the same for SGA and 
AGA infants (0,10 c~). 
5. The mean daily mass gain was 21,2 g/day. The mean daily length gain 
I 
6. Birth mass was regained by 6 days in infants -with birth mass between 
1001 and 1500 g. On this day, the caloric intake was 110-129 cal/kg. 
There was no difference between ORAL and PARENTERAL groups in time taken 
to regain birth mass. 
7. The possibility of excessive IV fluid volume (especially in infants -with 
birth mass less than 1000 g) accounting for mass gain is entertained. 
8. As a crude clinical estimate, the energy requirement of infants less 
than 1500 g is 110-130 cal/kg/day, and a daily IV volume of 100-120 
ml/kg most suitable for· the first week. 
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PART 3 
HAEMATOLOGY AND BIOCHEMISTRY 
(a) HYPERBILIRUBINAEMIA 
(b) HAEMATOLOGICAL VALUES 
I 
( c) ACID-BASE AND BLOOD GAS EsrIMATIONS 
(d) SERUM CHEMISTRY 
{e) URINE CHEMisrRY 
(f) COMMENT 
{g) SUMMARY 
(a) HYPERBILIRUBINAEMIA 
The incidence of hyperbilirubinae.mia (clinically obvious jaundice) 
during the first post-natal week was 62,3% (54/86 infants). Phototherapy 
was commenced when the total serum bilirubin exceeded 6 mgm %. There was 
no significant difference (p> 105) in the incidence of hyperbilirubinaemia 
between the ORAL group (25/43 infants) and the PARENTERAL group (29/43 infants). 
Bilirubin levels · 
There was rto significant diff~rence in the level of hyperbilirubin-
aemia between the two groups for any of the 7 days. 
Fig. 27 shows the scatter of total serum bilirubin levels for the 
total group during the first week. 
Fig. 27. 
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The highest recorded total bilirubin level was 14,5 mg%. 
No exchange transfusions were performed. The maximum incidence of jaundice 
occurred on the 3rd day in the ORAL group and the 4th day in the PARENTERAL 
group. Only one infant appeared jaundiced on the first day. 
The serial mean values of total serum bilirubin for the total 
group are shown in Table XXII, and the mean .Values for both groups in Fig.28. 
TABLE XXII 
Fig. 28 
TOTAL SERUM BILIRUBIN (TSB) 
TSB 
DAY 
mean + 
-
1 
-
2 6,03 
3 1,05 
4 7,19 
5 7,16 
6 6,30 
7 5"83 
n = sample size 
alLI UBIN 
1 2 3 4 6 
DAYS 
0 = ORAL P = PARENTERAL 
n 
SD 
-
I 1 
0,40 18 
0,31 49 
0,32 52 
o,J8 44 
0,44 36 
0,52 24 
SD= Standard deviation of the mean 
p ) ,05 
6 7 9 
7 4 
COMMENT 
Severe hyperbilirubinaemia was not encountered in this study. 
The relatively low levels of TSB could be attributed to early continuous 
phototherapy and early feeding practices (Smallpiece, 1964; Wharton, 1965; 
Wu, 1967). 
Although clinical ~igns of kernicterus were not observed in this 
study, they have ·been reported to occur at TSB levels in excess of 18,5 
mg% (Akerman, 1970) and others have reported its occurrence in low birth 
mass infants at levels between 8 7 8 and 17,8 mg% (Harris, 1958; Gartner, 1970; 
Keenan, 1972). Authors stress that the clinical state of the infant, 
presence of absence of illness or asphyxia, and administration of medications 
(including TPN) may influence the development of kernicterus. 
In addition there appears to be a correlation between neonatal 
TSB concentrations and later developmental status (Boggs, 1971; Crichton, 
1972). 
Keenan (1972) advises commencement of phototherapy at TSB 
concentrations of 8 mg%. In view of the concentrations found in this study 
(see Table XXII) commencement of phototherapy at 6 mg% would appear to be 
rational. 
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(b) HAEMATOLOGICAL VALUES 
The haemoglobin, packed cell volume (PCV), wnite blood cell 
count and reticulocyte count for the ORAL and PARENTERAL groups were observed 
for 6 weeks . 
The serial mean values for each group are shown in Table x.v, 
Appendix. These are illustrated in Figs. 29, 30, 31 and 32. 
Fi g. 29. 
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Fig . 31 
Fig. 32 
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No statistically significant difference between the ORAL and 
PARENTERAL groups for any of the above parameters at any stage could be 
detected . (p > 105) 
COMMENT 
Haemoglobin and PCV and Reticulocyte count. 
Apart from the first day, the serial estimations do not 
represent normal values for preterm infants, as samples of blood were 
being withdrawn at frequent intervals (see Fig. 11, Chapter II) from both 
groups . The haemoglobin and packed cell volume fell rapidly from bith. 
A PCV of less than JO% was not uncommon afte,r 10 days. In view of 
frequent sampling, all infants were given a transfusion of blood (25 ml/kg) 
when the PCV dropped below JO%. Transfusion was not given before the 10th 
day or within 5 days of the day on which the 30th day amino acid sample 
was taken. Despite transfusion, the haemoglobin and packed cell volume, 
after temporary elevation, continued to decline. 
+ The mean total haemoglobin value on the first day was 161 99 - 0,35 g% 
(range 8 75 - 22,4 g%) similar to that (15,6 g%) reported by Silverman (1961) . 
I 
The mean total PCV value on the first day was 47,60 ± 1111 (range 28 - 75, 6% ) 
similar to 50% reported by Stevens (1965) . 
The reticulo~yte count followed a similar pattern to that shown 
by haemoglobin and the PCV. There was evidence of a reticulocyte response 
at 6 weeks . The mean reticulocyte count for the total group on the first 
day was 9,0 ± 0,9% (range 8 - 26,8%). 
Erythropoietin levels in the blood, high at birth and the first 
week of life , are known to decline, activity returning at about 2 to J 
months. Decreased red blood cell production results in the 11 physiological" 
anaemia of the preterm infant which occurs between J and 7 weeks after birth. 
Minimal haemoglobin values vary from 6.5 to 9 g% and are the stimulus for the 
infant to commence erythropeoisis (O'Brien, 1971). Despite the fa ct that 
transfusion is consequently rarely indicated, lt was considered necessary to 
replace the blood which had been removed by sampling. 
Anaemias indicative of folate or Vitamin E 'deficiency were not 
observed (Oski, 1967; Ritchie, 1968). 
78 
White blood cell count (WBC). 
The WBC count on the first day showed a mean value of 
11,336 ! 790 cells/mm3 (range 500 - 44700 cells/mm3). Although the level · 
appeared raised at 10 and 20 days, there was no significant change during 
the first 6 weeks (p )>05). 
In the prediction of the presence of perinatal infection, the 
. 
WBC count proved disappointing. In cross-tab~lations with infant mortality, 
presence of infection in the gastric aspirate, histologic evidence of placental 
inflammation and immunoglobulin M (IgM) values, no positive correlations 
of statistical significance were detected , either at birth or at 10 days. 
f 
I 
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(c) fi._(::ID-BASE AND BLOOD GAS ESTIMATIONS 
It vas not the intention of this study to determine the normal 
acid-base values for infants of low birth mass. Determinations were 
performed primarily to assist rational management and therapy. If the infant 
was found to have a metabolic acidosis, correction was attempted with the 
calculated necessary number of milliequivalents of 4% Sodium Bicarbonate 
according to the "daily Astrup readings. 
The serial mean acid-base values for the ORAL and PARENTERAL 
groups are shown in Table . XVI, Appendix. 
Graphs il~ .. ustrating the serial values for pH, pC.02 and base 
excess (BE) appear in Figs. 33, 34 and 35. 
0 = ORAL group and P = PARENTERAL group. 
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There vas no significant statistical differences (p) ,05) for pH, 
pC02 and base ·excess in the ORAL and PARENtERAL groups for. the peri od from 
birth to 28 days. The base excess from the 4th to the 8th day (Fig.35) 
was lover in the PARENTERAL group, but was only significantly different at 
the 10% level on the 8th day. From a clinical vie'Wp()int, similar quantities 
of base vere administered to the two groups. 
The pH was highest on the 2nd day for both groups Yi.th a rise from 
the values at birth and dropping thereafter by the 4th day as a metabolic 
acidosis developed (Stevens, 1965). There was a slow rise in pH during the 
+ next 24 days to 7,32 - o,33 at 28 days. 
The pC02 fell after birth Yi.th the development of metabolic acidosis, 
and rose steadily to reach maximum values between the 10th and 14th days 
wi L1 correction of the acidosis. 
The p02 at birth 
Because of the wide range of inspired oxygen concentrations (Fi02 ) 
used at birth, a comparison of the pA02 values was not possible. When 
calculating the pA02 : pa02 gradient for these infants, a Yi.de range between 
1,5 and 4,5 was found. The gradients were plotted against gestational age, . 
but no correlation was found between these parameters. 
The pA02 was only used to assist the clinical management of these 
infants, and the above findings are not regarded as meaningful. 
8 1 
COMMENT 
The low birth mass preterm infant is prone to metabolic acidosis. 
(Reardon, 1950). pH values similar to those found in this study have been 
reported (Pincus, 1956; Kildeberg, 1964). In small preterm infants marked 
metabolic acidosis is found at 4 to 5 days. The acidosis is due to perinatal 
distress (particularly asphyxia), increased tissue metabolism, inefficient 
renal function and variations in fluid and calorie intake (Bucci, 1965). 
The fact that acid-base values have not returned to normal by 28 
days is possibly explained by the late type of metabolic acidosis described 
by Kildeberg (1964a). He attributes this acidosis to a temporary 
disproportion between renal capacity for hydrogen ion excretion and the 
daily load of non-volatile acid which in these infants may be due to low 
nitrogen retention and increased urinary loss of lactate. 
It is interesting to note that TPN infusion had no significant 
effect on acid-base homeostasis in these infants. Continuous infusions 
of concentrated glucose solutions (~ 20%) in immature dogs does not cause 
lactic acidaemia (Nakajima, 1973). Fructose infusions exceeding 1 g/kg/hour 
produce clinically significant acidosis and will exacerbate further acidosis 
in patients who are already acidotic (Bergstrom, 1968). In this study, 
glucose infusions did not exceed 1 g/kg/hour, which probably accounts for the 
fact that increased acidosis was not observed during TPN. 
Chan (1972) observed that acidosis complicated TPN in preterm 
infants. He also used casein hydrolysate and found that the maximal net 
acid excretion in response to the exogenous acid load was achieved slowly 
(9 days). The acidosis ~as eliminated if TPN vas discontinued and could be 
effectively corrected with bicarbonate. It is possible that sign:ifi.cant 
acidosis was not observed in this study because of the daily correction with 
bicarbonate. 
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( d) SERlM CHEMI STR'.{ 
The serial mean values for serum sodium, potassium, chloride, 
osmolality, calcium, inorganic phosphate, blood urea, serum glutamic 
oxaloacetic transaminase (SGOT), cholesterol, total protein, albumin and 
83 
globulin for the ORAL and PARENTERAL groups appear in the Appendi~, Tables XVII to 
XX . The significant statistical differences (when present) between the 
groups are indicated in Figs . 36 to 47. 
There were no significant statistical differences between the ORAL 
I 
and PARENTERAL groups within the first 24 hours of birth for any of the bio-
chemical parameters studied, therefore the mean values for the total group 
(86 infants) are shown in Table XXIII and c._ompared· with values for preterm 
infants reported by other authors. 
TABLE XXIII 
SERUM BIOCHEMICAL VALUES WITHIN 24 HOURS OF BIRTH 
MEAN ± SD RANGE REPORTED VALUES 
Sodium (meq/1) 140,19 1,68 110 - 169 
Potassium (meg/1) 4,98 0,12 2,8 - 9 
Chloride (meq/1) 100,69 o,68 84 - 115 
Osmolality (mosm/1) 272,79 3,28 239 - 318 
Urea (mg/100 ml) 30,81 1,98 5,7 - 103 
Calcium (mg/lOOml) 7,86 0,16 4,8 - 12,5 
Phosphate (mg/100 ml) 5,81 0,17 2,4 - 12,5 
Cholesterol (mg/100 ml) 141,17 6,10 · 111 - 396 
SGOT (units/100 ml) 18,54 1,20 O - 64 
Total protein (g/100 ml) 5,05 0,09 3 - 8.8 
Albumin (g/100 ml) 2,87 0,07 1,6 - 4 
Globulin (g/100 ml) 2,19 0,08 1 - 5,9 
* Auld, 1966 
SD= Standard deviation of the mean 
** Davis, 1966 
133 - 146 
5,1 - 5,5 
98 - 104 
285 ± 15 
15 - 40 
(BUN 18.9) 
7 - 10,5 
5 - 6,7 
? 
0 - 70 
5,5 
4 
1,2 
+ Stevens, 1965 
++ Mccance, 1947 
r/ Radde, 1971 
BUN= Blood urea nitr~gen (mg/100 ml) 
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Ele ctrolytes 
The mean serum potassium (4,76 ! 0,17 mequiv/1) for the PA..'lENTERAL 
+ group was significantly · higher (p<,05) than the ORAL group (4,33 - 0,17 
mequiv/1) on the 5th day, (Fig. 37) but still within the normal range. 
No significant differences between the groups for sodium and chloride were 
detected. 
Osmolality 
The serum osmolality during TPN in the PARENTERAL group was 
significantly higher than the ORAL group at 10 days (p< ,05). The elevated 
level on the 5th day was significant only at the 10% level (Fig. 39). The 
serum osmolality returned to normal after TPN was discontinued. 
Calcium and phosp~at~ 
The mean values for serum calcium (Fig. 40) in the PARENTERAL 
group were significantly higher on the 5th and 10th days (p( ,05), but still 
within the normal range. The serum calcium in the ORAL group rose steadily to 
reach maximum levels at 21 days. 
No significant difference in serum phosphate (Fig. 41) between the 
t"1o groups ws detected. There was very little change in serum phosphate 
levels throughout the first month. 
Blood urea 
The blood urea (Fig. 42) wa.s significantly raised on the 5th day in 
the PARENTERAL group (p< 1 05). The blood urea in both groups fell gradually 
until 10-14 days and then remained stable. 
SGOT and Cholesterol 
There "1ere no differences in SGOT values bet"1een the t"'o groups . 
SGOT levels declined slightly throughout the first month. 
A highly significant difference (p < ,001) was observed in serum 
cholesterol levels between the t-wo groups. In the PARENTERAL group there ws 
a marked increase in serum cholesterol on the 5th, 10th and 14th days (Fig. 44). 
Dy 21 days no difference botween the two groups could be detected. 
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Total protein, albumin and globulin 
Total protein, albumin and globulin values remained remarkably 
constant throughout the first month. There was no significant difference 
at any time between the two groups. (Figs. 45 to 47). 
NOTE : 
Glucose 
No statistical analyses were perfo.rmed on blood or urine glucose 
estimations. The Dextrostix (Ames) test for blood sugar and the Clinitest 
(Ames) for urine sugar were performed as part of the clinical management of 
the infants (see Fig . 11, Chapter II). High or low blood sugar readings 
were checked by more precise laboratory methods (Appendix, _Table VII). 
Symptomatic hypoglycaemia occurred in one infmt (No. 70) before 
IV dextrose was given on the first day. 
Hyperglycaemia (blood sugar )130 mg% on Dextrostix) was seen in 
5 of the 43 infants in the PARENTERAL group during the first 3 days of 
infusion and not thereafter. 
During the 5 hour period of Intralipid infusion, quantitative 
90 
blood sugar estimations were done at hourly intervals in 6 infants (Fig. 48). 
The blood sugar level at the commencement of the infusion {approximately 100 mg% ) 
dropped to a minimum level by 2 hours and then rose slowly to reach 80 to 
100 mg% at the end of 5 hours. It was impoDtant to eliminate the possibility 
of hypoglycaemia during this period. The slow rise in blood sugar observed 
was probably ~ue to gllconeogenesis (Haworth, 1973). 
Losses of sugar in the urine during TPN did not exceed 1% 
(Clinitest Oto 2+). This loss is similar to that reported by others 
(Das, 1970; Filler, 1970). 
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(e) URINE CHEMISTRY 
The serial mean values of sodium, potassium, chloride, urea, 
and creatinine excreted in the urine, together with the urinary osmolality, 
for the ORAL and PARENTERAL groups appear in Appendix, Tables XXI and XXII. 
The significant statistical differences (p<_,05), when present, 
betyeen values for the ORAL and PARENTERAL groups are indicated in Figs. 
49 to 54. 
There yere no significant differences between these groups within 
the first 24 hours after birth for any of the biochemical parameters studied 
(p;>,05), therefore the mean values for the total group are shoyn in Table XXIV. 
TABLE XXIV. 
URINE BIOCHEMICAL VALUES WITHI N 24 HOURS OF BI RTH 
MEAN 
Sodium (meq/1) 45,94 
Potassium (meq/1) 22,~9 
Chloride (meq/1) 21,73 
Urea (mg/100 ml) 448,94 
Creatinine(mg/100 ml) 16,19 
Osmolality(mosm/1) 209,90 
(sample size= 86 infants) 
SD= Standard deviation. 
+ SD 
- I 
2,95 
1,96. 
2,00 
30,58 
1,23 
9,68 
RANGE 
3 - 156 
2 - 118 
0 - 74 
24 - 999 
4 - 76 
85 - 480 
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Electrolytes 
No particular pattern in the excretion of electrolytes in the 
urine could be detected during the first 28 days. The urinary loss of 
potassium on the 5th day (Fig. 51) and chloride on the 10th day (Fig. 50) 
was significantly less .in the PARENTERAL group than the ORAL group (p<,05) 
Osmolality 
The urinary osmolality was relatively stable for the first 28 
days , except for the mean values obtained on the 5th and 10th days of TPN 
in the PARENTERAL group which were significantly (p(,05) higher than 
values obtained in the ORAL group for the corresponding days (Fig.52). 
Urea and creatinine 
Excretion of urea in the urine was significantly higher (p<.,05) 
in the PARENTERAL group on the 10th and 14th days (Fig. 53). There was no 
significant difference in creatinine excretion (Fig. 54) between the ORAL · 
and PARENTERAL groups. (p )" ,05). 
~ 
(f) cm,a.fENT 
The concentration of the various constituents of the parenteral 
solution influenced the biochemical results during the first 14 days. 
Newborn infants retain approximately 2 · meq/1 of sodium daily 
during the first week while on breast milk. Borreson (1970) estimated the 
optimal daily parenteral requirement of sodium to be 1,05 m~q ·/kg/day. 
From the normal serum sodium values obtained,. ·the concentration used 
(2,8 · meq/1) in the parenteral solution would not appear to be excessive. 
The sodium intake in the ORAL group was 2,2 . meq /kg/day. Urinary losses 
of sodium were the same for both groUDS• 
There is a considerable fall in serum potassium after birth 
(Widdowson, 1956). A fall in serum potassium was observed by the 5th day in 
the ORAL group despite adequate intake of potassium (4 m~q/.kg/day) •. 
Although the potassium intake was less (1,6 . meq /kg/day) in the PARENTERAL 
group, this fall was not observed. Correspondingly, the potassium losses 
in the urine during TPN were less than losses incurred in the ORAL group, 
indicating good renal tubular reabsorption (Helmuth, 1972). The estimated 
daily parenteral requirement of 2 meq/.kg _ (Borreson, 1970) for newborn 
infants would also appear to be satisfactory for low birth mass infants. 
Plasma osmolality and serum sodium bear no fixed relationship to 
each other during the first week of life (Davis, 1966). The·. serum 
osmolality of the ORAL group (Fig. 39) dropped steadily from birth to 14 
days when -values in the lower range for normal full term neonates were 
observed. The serum osmolality during TPN showed a marked increase, 
reaching maximum levels (281,38 ~ 2,67 . mosm/1) by the 10th day (upper 
range for normal full term neonates). The osmolality of the casein hydrolysate 
is approximately 1000 . mosm/1, . while the fat emulsion (Itralipid 10%) 
is iso-osmolar. The results reflect the effect of the high osmolar load of 
the infusate on serum osmolality. The urine ·showed a corresponding increase 
in osmolality d\U'ing TPN. Urine solutes could be concentrated to 805 
mosm/1 indicating a renal concentrating power equivalent to that observed 
in full term infants (Pratt, 1948). Normal levels of serum osmolality 
during TPN have been reported (Ghadimi, 1971a; WeL, 1972) and increased 
levels by Helmuth (1972). The rate of infusion of the parenteral solution 
in 1000 g infants was 6,3 ml/hr or 0,1 ml/minute. This represents 0,01% -
of the minute return from the inferior vena cava (Ghadimi, 1971) and explains 
why the serum oslllii)lality did not exceed the normal range. 
The concentration of calcium in the parenteral solution was 
0,8 meq/kg compared with 2,6 meq/kg in Nan. Despite this, significantly 
higher values for serum calcium were observed in the PARENTERAL group during 
TPN, although they were still within the normal range. The daily parenteral 
requirement of approximately 1-2 . ~q/kg · (Borreson, 1970) would appear 
satisfactory. Driscoll (1972) and Bryan (1973) reported normal calcium 
levels during TPN . 
Hypophosphataemia commonly complicates TPN when insufficient 
phosphate is added (Bryan, 1971; Ruberg, 1971). The daily intake of 
phosphate was 2,4 meq/kg for both the PARENTERAL and ORAL groups. The 
fact that there was no significant difference in serum levels of phosphate 
between the two groups probably indicates good alimentary absorption of 
phosphate . As reported by others, (Driscoll, 1972; Bryan, 1973) serum 
phosphate levels were normal during TPN. 
Williams (1963) reported no relationship between blood urea levels 
and oral protein intake in infants weighing less than 1500 g at birth. 
On the co~trary, a parenteral protein intake exceeding 4 g/kg/day results in 
azotaemia (Driscoll, 1972; Duncan, 1972). The blood urea is frequently 
raised during TPN (Bryan, 1971; Helmuth, 1972) but returns to normal when 
it is discontinued (Ghadimi, 1971 a; Subramanyam, 1972). Despite increasing 
oral protein intake, the blood urea fell gradually during the first 10 days 
in the ORAL group. During TPN, the blood urea was significantly elevated 
on the 5th day, but returned to normal levels when TPN was discontinued (Fig. 
42). There was a correspondingly increased excretion of urea in the urine up 
to the 14th day . There is probably an acceleration of the Kreb 1 s urea 
cycle adapting to the load of exogenous ammonia and amino nitrogen provided 
-by the casein hyrolysate (Ghadimi, 1971 a). 
SGOT levels show no important change in relation to age (Stave, 
1960). There were no significant changes in SGOT levels for either group _ 
in this study. Ghadimi (1971) reported raised SGOT levels in 2 of his 10 
low birth mass infants receiving TPN. 
The actual protein intake (3,2 g/kg/day) was the same for both 
groups and complied with recognised protein _requirements for preterm infants 
(Holt, 1959; Snyderman, 1968). There does not appear to~be any advantage 
in increasing the protein intake above 3,5 g/kg/day (Williams, 1963). No 
significant differences between the two groups for total protein, albumin 
or globulin could be detected. Wei (1972) reported restoration of subnormal 
values of albumin to normal with TPN. It is deduced that normal levels 
of :.otal protein, albumin and globulin were maint ained during TPN. 
Perhaps the most significant biochemical finding was the presence 
of high serum cholesterol levels during (and just after) TPN in the PARENTERAL 
group. Intravenous fat has a sparing effect on protein stores and promotes 
positive nitrogen balance (Reid, 1967). The removal of fat particles from 
the bloodstream takes place in the same way as that of chylomicrons because 
the emulsion particles are less than 1 micron in diameter. (Wretlind, 1964). 
In Intralipid, 85% of the fatty acids are unsaturated (Harries, 1971 a). 
After infusion, two thirds of the plasma free fatty acids (FFA) are found to 
be derived from exogenous FFA (Wadstr~m, 1964). Linoleic acid is essential, 
and a deficiency may be induced by fat-free TPN (Paulsrud, 1972). Acute 
side-effects of intravenous fat infusions are rare (Schuberth, 1964) and the 
late effects ( 11 overloading syndrome") with hyperlipaemia and a haemorrhagic 
diathesis (Amris, 1964) uncommon with soya bean emulsions. Preterm infants 
have a maximum clearance of fat of 618 g/kg/day (Harries, 1971 a). When 
using Intralipid at 2 g/kg/day, Wei (1972) noted that the plasma levels of 
FFA and triglycerides were markedly raised . We used 4 g/kg/day which was 
the same as given 'By others. At this concentration, Duncan (1972) also · 
reported raised cholesterol 1levels in the serum. 
The raised serum cholesterol probably results from increased amounts 
of FFA and triglycerides providing excess substrate to the endogenous 
lipoprotein fraction of the serum. The significance of high serum cholesterol 
levels over this short period is not clear. 
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(g) SUMMARY 
1. The dextrose/amino acid infusate appeare~ to meet the electrolyte, calcium, 
phosphate and protein requirements of the infants studied and did not 
result in serious biochemical abnormalities . 
2. During TPN the values for serum sodium, potassium, chloride, calcium and 
phosphate were within normal limits , although the values for serum potassium 
and calcium were significantly higher than those observed in the ORAL group. 
J. Although within the upper range for normal, the serum osmolality during 
TPN was significantly higher than that of the ORAL group, due to the high 
osmotic load of the infusate. 
4. The blood urea during TPN was significantly higher than values observed for 
the ORAL group (though not out of the normal range). 
5. There was no significant difference in serum total protein or SGOT between 
the two groups. 
6. Hyperglycaemia and glycosuria during TPN was infrequently observed. 
7. Biochemical values of urinary electrolytes, urea and osmolality reflected 
changes in the serum and indicated adequate renal function in these low 
birth mass infants. 
8. Cholesterol levels were markedly raised during TPN but returned to normal 
limits once TPN was discontinued . Lower concentrations of Intralipid than 
4 g/kg/day should probably be used until the significance of these 
levels is understood. 
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THE PERINATAL INFECTIVE ENVIRONMENT 
1 . INTRODUCTION 
Infection has long been recognised as a major cause of morbidity 
in newborns and is the primary cause in approximately 20% of neonatal 
deaths (Sprunt , 1959; Benirschke , 1960). The incidence is probably higher 
for low birth weight infants . 
A major clinical problem is the difficulty in diagnosing infection 
due to the paucity of signs exhibited and the consequent delay in treatment. 
For this reason, information concerning the infective environment must be 
sought to enable early and rational treatment to be given (Sprunt , 1959). 
An analysis of the causes of death and clinical complications 
appears in Table XVII. Infection was the primary cause of death in 6 of the 
15 infants, and was responsible for 52% of the clinical complications. 
In order to gather as much information about ,the perinatal infective 
environment,as possible, the duration of rupture of the membranes was noted, 
the serum im.amnoglobulin M value was estimated and cultures obtained from 
ear, cord stump, gastric aspirate, stool and blood within a few hours of 
birth on all patients. In addition, a pus cell count was performed on the 
gastric aspirate and the placenta was histologically examined. The methods 
for these procedures appear in Chapter II. 
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2. RESULTS 
(a) The Placenta 
73 placentas were examined. Those vi.th no evidence of 
inflammation or evidence of chorioamnionitis only were regarded as 
normal. When there was evidence of funicitis or placentitis t he placenta 
was regarded as i ·nfected (Benirschke, 1959)!,· 
TABLE llV 
PLACENTAL HISTOLOGY 
TOTAL ORAL PARENTERAL 
% vi.th normal placenta 28,9 (43) 51,43 (18) 65,79 (25) 
% with infected placenta 41,1 (JO) 48,57 (17) 1 34,21 (lJ) 
(NOTE: The sample size is given in brackets). 
2 
x Yates = 1,016 No significant difference p.)0,05 
There was no significant difference in the incidence of placental 
infection between the ORAL and PARENTERAL groups. (Table XXV). The 
incidence of infected placentas for the total group was 41,1% (J0/7J). 
A significantly higher (p (,01) number of infants vi.th infected 
placentas died (11/JO) than those with normal placentas (4/43) as shown 
in Table XXVI. 
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TABLE XX.VI 
I 
PLACENTAL HISTOLOGY IN RELATION TO MORTALITY 
MORTALITY 
Placental ORAL PARENTERAL TOTAL 
Hist ology Alive Dead Alive Dead Alive Dead 
Normal 16 2 23 2 39 4 
Infected 13 4 6 7 19 11 
29 6 29 9 58 15 
2 (X total= 8~1052: p <: ,01) 
There yas no correlation betyeen placental inf~ction and 
positive cultures of the gastric aspirate, ear, cord, blood and stool 
(Appendix, Table XXXIII). 
+ The infant-placenta ratio for AGA infants Yas 7,42 - 0,12 and 
the ratio for SGA infants Yas 5, 02 ~ 0,37 . 
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(b) The Gastric Aspirate 
The gastric aspirate was examined for the presence of pus cells. 
The absence of pus cells or the presence of less than 5 pus cells per high 
power field was regarded as normal. The presence of more than 5 pus cells 
per high power field was regarded as indicative of infection. 
The incidence of infection by these criteria was 25,6% (22/86) 
in the gastric aspirates for the total group •. There was no significant 
difference in the incidence of infection between the ORAL and PARENTERAL 
groups (Appendix, Table XXIII). 
There was a significant correlation between placental infection 
and gastric aspirate infection (Table XXV:II) 
TABLE XXVII 
PLACENTAL HISTOLOGY IN RELATION TO THE GASTRIC ASPIRATE 
' 
PLACENTAL GASTRIC ASPIRATE 
HISTOLOGY 
ORAL PARENTERAL TOTAL 
Normal Infected Normal Infected Normal Infected 
Normal 17 1 22 3 39 4 
Infected 10 7 6 7 16 14 
27 ·a 28 10 55 18 
2 ( X = 11.3.447 ; P< ,001) 
There was no correlation between placental infection and positive 
cultures of the gastric aspirate, ear, cord, blood or stool (See Appendix, 
Table XXIII). 
There also appeared to be an association between significant numbers 
of pus cells in the gastric aspirate and mortality, although this was not 
statistically significant (Appendix, Table XXIV}. 
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(c) Duratio n of runture of the membranes 
The duration of rupture of the foetal membranes ranged from 0-624 
hours. The obstetric policy of delaying premature labour by the administrat ion 
of cort isone and salbutamol (Liggins , 1973) tended to prolong the interval 
between rupture of the membranes and delivery. 
Our policy was to give antibiotics to infants in whom the membranes 
had been ruptured for more than 24 hours (a.f.ter the appropriate specimens 
had been taken). 
The mean time of rupture of the membranes for the total group 
+ was 40,8 - 10 73 hours . There was no statistically significant difference 
in the duration of rupture of the membranes between the ORAL and PARENTERAL 
groups (Appendix, Table XXV). 
Because of the wide scatter and range of duration of rupture 
of membranes, only two time categories (less or greater than 24 hours) were 
I 
used for statistical analysis . 
There was no correlation between duration of rupture of the 
membranes and mortality (Appendix, Table XXVI), neither was there a 
significant relationship between duration of rupture of the membranes and 
the degree of placental infection (Appendix, Table XXVII), indicating that, 
for this study, prolonged periods of rupture of the membranes before 
delivery did not place the infant at risk. 
Lengthening periods of rupture of the membranes did not increase 
the i ncidence of gastric aspirate infection as judged by the pus cell count 
(Appendix, Table :XXVIII). 
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(d) Cultures of the gastric aspirate, ear, cord, blood and stool. 
There was no significant difference in the incidence of positive 
cultures for any of these parameters between the two groups (Appendix, Table 
XXIII. 
The incidence of positive cultures from these sites is summarised 
in Table XXVIII. 
-TABLE XXVIII 
INCIDENCE OF POSITIVE BACTERIOLOGICAL CULTURES (86 infants). 
SITE POSITIVE CULTURE NO GRDWI'H INCIDENCE % 
Ear 32 54 37,2 
Stool 22 64 25~5 
Cor d 19 67 22,1 
Gastric a spirate 12 74 13,9 
I 
Blood 3 83 3,5 
Of the multiple site cultures, only positive ear cultures were 
significantly related to mortality. Of the 32 infants with positive cultures 
from the ear, 9 died compared with 6 of the 54 infants with negative cultures 
at birth. The mortality was significantly higher (x2 = 2,9441, P<,05) in 
those infants with positive cultures from the ear. 
Apart from the above observation, there were no significant 
correlations for infection in any of the sites with the presence of infection 
either in the gastric aspirate or in the placenta (see Appendix, Table XXIII). 
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(e) Immunoglobulin M (IgM) 
The laboratory method for determining IgM in the blood was used_ as 
a screening procedure for the presence of infection. Values were reported as 
~ 25 mg/100 ml blood (normal) or, if the value was greater than 25 mg/100 ml 
clood, a precise determination was given . 
The incidence of raised IgM values ·was 20% (19/86 infants). In 
3 infants there was marked elevation of the I gM levels (218-275 mg/100 ml). 
All 3 infants were SGA and born of the only mothers with positive serological 
evidence of. syphilis, although no evidence of the diseas·e was detected in 
the infants. 
When relating the I gM levels of the infants to the duration of 
rupture of membranes, white cell count at birth, mortality, gastric aspirate 
(pus cells), placental histology and cultures from multiple sites, there was 
no significant correlation (p.>,05). 
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:,. COMMENT 
Bacterial infections in the newborn infant are overwhelmingly 
due to ascending infections from the vagina (Benirschke, 1960). Fatal 
neonatal bacterial infection acquired in utero is always accompanied by 
inflammation of the amniotic sac (Benirschke, 1959). Foetal infection is 
indicated by the microscopic finding of inflammation of the wall of the 
umbilical vein, however the incidence of this finding far exceeds that 
recorded for clinical neonatal infection (Benirschke, 1959). This shows 
that the infant has been exposed to an infected environment , but is not 
necessarily infected. (Benirschke, 1967). 
Benirschke ,(1967) also showed that the incidence of umbilical 
vasculitis (funicitis) increased with shortening gestation and that below 
32 weeks this was 26 to 4Z'/o, similar to that (41%) found in this study. 
Not all of these infants developed clinical sepsis but, in 11 
of the 15 infants (7J%) who died there was evidence of funicitis and/or 
placentitis, proving that mortality is significantly related to placental 
infection. (Table XXVI). Gunn (1970) found , that there was 
amnionitis in 61% of the infants who died of infection. 
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Blanc (1953) detected evidence of inflammation from a smear of the 
f oetal surface of the placenta and the presence of leucocytes in the gastric 
aspirate. The detection of pus cells i ~ the gastric aspirate has been used in the 
prediction of infection in the newborn (Blanc, 1959; Ra.mos, 1969). In this 
study, the incidence of more than 5 pus cells per high power field in the 
gastric aspirate was 25% which was the Sc!-file as that reported by Blanc (1959). 
This rose to approximately 50% in those who died (7/15), indicating that 
mortality is significantly associated with an infected gastric aspirate. 
(Appendix, Table XXIV). 
Although the incidence of placental infection (41%) is higher than 
the incidence of gastric aspirate infection (25%), a strong correlation between 
them was detected. 
Prolonged rupture of the membranes before delivery has been 
related to an increase in the clinical sepsis rate (Pryles , 1963). However, 
the suspicion of clinical sepsis was only confirmed in a quarter of these 
cases. Gillibrand (1967) found that infection associated with prolonged 
rupture of the membranes was not a major contributing factor to perinatal 
mortality. In this study, no relation of prolonged rupture of the membranes 
to mortality, placental infection or infecti?n of the gastric aspirate 
could be demonstrated. There did not appear to be a significant increase in 
the infected environment with prolonged rupture of the membranes. 
Correlations between bacterial cultures and placental infection or 
infant morbidity are not clear (Wilson, 1964) • . Scanlon (1971) advocates 
examination of the liquor obtained from the external ear canal for the early 
detection of neonatal sepsis. In this study, the ear swab produced the highest 
incidence of positive cultures (37,2%) and was the only culture to correlate 
I 
significantly -with mortality. 
Antibiotics given to infants of mothers -with prolonged rupture of 
the membranes do not improve perinatal mortality, but do lower post-partum 
morbidity (Lebherz, 1963; Gunn, 1970). The use of prophylactic antibiotics 
is not advocated by some authors (Blanc, 1959; Pryles, 1963). The collective 
evidence principally obtained from the presence of pus cells in the gastric 
aspirate, histology of the placenta and culture of the ear fluid demonstrates 
an increased risk of, or exposure to, infection in the newborn and should make 
the decision to use (and the choice of) an antibiotic more rational. 
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4.· SUMMARY 
I 
1. There ±s a high incidence of placental infection in low birth 
infants (41%). 
2. The incidence of significant numbers of pus cells in the gastric aspirate 
in these infants is 25%. 
J. 
4. 
5. 
There is a significant association between placental infection and the 
presence of infection in the gastric aspirate. 
The highest yield of positive cultures was from the ear (37%). 
placental infection, gastric aspirate infection and positive cultures 
the amniotic fluid present in the ear after birth are significantly 
related to neonatal mortality. 
from 
6. The duration of prolonged rupture of the membranes bears no relation to 
neonatal mortality or to the incidence of infection. 
7. Rational antibiotic therapy should be based on the information derived 
from the histologic examination of the placenta, microscopic examination 
of the gastric aspirate and culture of the ear swab. 
8. The results of these tests should be regarded as suspicious of, but not 
diagnostic or, imminent sepsis in the neonate. 
9. There was no statistically significant difference in infection, both 
prenatal and postnatal, bet1,,1een the ORAL and PARENTERAL groups. This 
indicated that the procedure of TPN itself did not significantly increase 
the incidence of infection in the PARENTERAL group. 
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1. INTRODUCTION 
One of the limiting factors of growth of the infant is the 
availability of the necessary amino acids in the correct concentrations at 
the same time. During infancy and childhood, the demand for amino acids is 
higher than for adults because of the increased rate of protein synthesis 
required for growth. 
The placenta has the ability to concentrate amino acids in the 
direction of the foetal circulation (Schrei:er~ 1955) . The level of amino 
acicsin the foetal blood is a function of the growth rate of the foetus 
(Schreier, 1955). This ability to concentrate amino acids is achieved by 
means of active transport which is known to occur from at least 19 weeks 
and is more pronounced in the early stages of pregnancy (Ghadimi, 1964a). 
No difference in concentrating ability between essential and non-essential 
amino acids has been observed , possibly-because the foetus must obtain both 
essential and non-essential amino acids from maternal sources. 
Ghadimi has established the base-line concentrations of free amino 
acids in cord blood in full term neonates (Ghadimi, 1964a). There are also 
reports of the free amino acid concentrations in the plasma of full term 
newborns after birth (Ghadimi, 1964b; Dickinson, 1965). 
There is evidence that plasma amino acid concentrations in preterm 
infants differ considerably from those in full term infants (Schreie~ 1955; 
Ghadimi, 1964b). However, base-line concentrations have not been established. 
While studying the 86 low birth mass infants with respect to 
f eeding methods, the opportunity arose to determine their free plasma amino 
acids by ion exchange chromatography. 
This was considered an.important venture because: 
(a) the base-line concentrations of amino acids for LBM infants could be 
established at birth,10 days and 30 days. 
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(b) the r esponse to humanised milk feeding with a protein intake of 
3,2 g/kg/ day could be observed in the ORAL group. 
(c) f olloiang reports of hyperaminoacidaemias in preterm infants during TPN 
(Das, 1970; Ghadimi, 1971a; Stegink, 1971 and Wei, 1972) it was important 
to determine which amino acids were elevated, to what extent and the 
possible significance of these findings in the PARENTERAL gro~p. 
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2. MATERIALS AND MEI'HODS 
1 ml blood was taken from the posterior fontanelle 'Within 
12 hours of birth, at 10 days and again at 30 days, and centrifuged 
(6 minutes at 5000 rpm). The plasma was removed by capillary pipette 
i 
and frozen at -20°c. When required the specimen was thawed and plasma 
0.2 ml placed in a conical centrifuge tube (2 ml). This was deproteinised 
by adding sulfosalicylic acid (0.8 ml 3% w/v; Hamilton, 1963). After 
mixing the precipitated proteins were removed by centrifugation (10 
minutes at 5000 rpm) and the clear supernatant was pipetted (usually 0.7 ml) 
into a clean test tube (5 ml) and an equal volume of citrate buffer (0,2N; 
pH 2,2) added. The final dilution was 1:10. This was injected on to the 
ion exchange column. 
The Beckman Model 120C Amino Acid Analyser built according to · 
Piez's modification (Piez, 1960) of the technique originally described 
by Spackman et al (Spackman, 1958) vas used. Its operational principle is 
based on elution chromatography from buffered columns of ion exchange resin. 
The separated components are subjected to reaction 'With ninhydrin and then 
quantitated 'With a colorimeter. The resultant peaks are recorded by a strip 
chart recorder. The reproducibility of results 'With this instrument is 
approximately 2-5%. The analyser is calibrated with a test solution of 
ana:l.ytic grade amino acids (Standard Calibration Mixture, Beckman, Type l, 
part No. 312220). Acidic and neutral amino acids were determined on a long 
column using Beckman Custom Research Resin Type AA-15, and basic amino 
acids were determined on a short column using Beckman Custom Spherical 
Resin Type Pa-35. 
A calibration run was used to determine the value of amino acid 
peaks as standard for ensuing samples. Fresh stock buffer solutions were 
prepared every month. 
The Standard Calibration mixture c~ntains 17 amino acids 
(L-lysine, L-histidine, L-arginine, L-aspartic acid, L)threonine, L-serine, 
L-glutamic acid, L-proline, L-glycine, L-alanine, L-cystine, L-valine, 
L-methionine, L-isoleucine, L-leucine, L-tyrosine, L-phenylalanine) and 
· 1 1 3 
I 
ammonium chloride (Beckman, 
21 5 ! 0,004 micromoles/ml. 
1965). Each is present at a concentration of 
The bottle was refrigerated after opening. 
Amino acid tracings (aminograms) were calculated manually by 
comparing the half-height by width of each peak with the half-height by width 
of the corresponding standard peak. With the small concentrations of amino 
acids encountered in the infant samples, the extended range of sensitivity 
was used, and the· ratio of this range to the· standard range taken into 
account by finding the mean ratio of all the peaks to the standard. Results 
were expressed in micromoles/100 ml. 
Altogether 25 low birth mass infants were studied. Their mass 
ranged from 800-1500 g and gestational age from 27-32 weeks. The number of 
samples estimated were: 
(a) First day - 25 
(b) Tenth day - 19 
(c) Thirtieth day- 14 
The lower numbers on the tenth and thirtieth days reflect 
intervening deaths. Of the 19 tenth day samples, 10 were taken at the 
conclusion of TPN. 
A tracing of a typical aminogram is shown in Fig. 55. 
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3. RESULTS 
(a) Plasma amino a·cids at birth 
The analysis of the plasma of 25 low birth weight infants is 
shown in Table XXIX. 
TABLE XXIX. 
FREE AMINO ACIDS IN BLOOD PLASMA OF PRETERM INFANTS W M/100 ml) 
AMINO ACID 
ASPARTI C ACI D 
THREONI NE 
SERINE 
GLUTAMIC ACID 
PROLINE 
GLYCINE 
ALANINE 
CYSTINE 
VALINE 
ME'THIONINE 
I SOLEUCINE 
LEUCINE 
TYROSINE 
PHENYLALANINE 
LYSINE 
HISTIDINE 
AR.GININE 
CORD* 
Preterm 
infants 
n = 7 
BIRTH 
n = 25 
lO ·DAYS 30 DAYS 
n = 9 n = 14 
FULL TERM + 
INFANTS. 
n = 29 
mean SD mean SD mean SD mean SD mean SD 
+ 2,6 .:..0,9 
+ 32,6 -5,9 
+ 16,2 -3,3 
+ 12,8 -7,1 
+ 16,8 -6,o 
·+ 26,5 "-3,2 
+ 41,1-15,9 
+ 11,4 -3,3 
+ 27,9 -3,9 
+ 213 .:..0,8 
+ 6,1 -1,4 
+ 12,0 -4,8 
+ 5,0 -3,4 
+ 7,2 -3,.5 
+· 48,4-16,5 
+ 11,8 -4,4 
+ 15,1 -2,8 
+ + 5,15-0~74 . 5,30-1,19 
+ + 15,27-1,98 33,15-5,96 
+ + 30,58-3,18 39,85-5,58 
29,86±3,85 39,71±6,89 
16,74±2,58 19,06!4,16 
37,66!4~14 47,66!5,76 
+ + 36,31-5,66 45,45-7,02 
+ · 8,50-1,40 
+ 22,40-3,03 
+ 37,02-5,24 
+ 36,60-6,79 
+ 0,4 -0,2 
+ 14,7 -4,0 
+ 11,4 -2.,0 
+ + 21,3~4,84 20,1 -6,2 
+ + 41,70-6,06 16,4 -2,9 
+ + 36,14-6,01 27,5 -7.,3 
+ + + + 5,6~1,05 2,22-0,75 8,02-2,78 5,37~1,3 
+ + + + 8,25-1,07 14,31-3,64 13,31-3,57 19,4 -4,9 
+ + + + 19,77-4,79 19,95-7,12 20,57-2,95 2,15-0,9 
+ + + + 7,23-1,26 6,25-1,12 10,73-1.,68 5,95-1,5 
+ + + + 9,48-1,36 9,85-1,65 13,22-2,42 10,4~3,l 
+ + + + 8,48-1,14 7,1~1,57 7,91-1,49 8,32-2,7 
+ + + + 9,37-2,14 7,18-0,86 9,10-1,95 · ~,21-1,4 
26,49±3,56 28,92±5,62 29,08±4,10 10,27±3,3 
+ + + 14,45-3,38 10,74-3,18 12,67-2.01 
+ + + 3,48.:..0,59 4,25-1,39 6,75-1,93 
+ 6.,2~1,0 
+ 4,77-1,3 
* Data of Ghadimi and Pecora (1964,a) 
+ Data of Snyderman and Holt (1968) 
n = sample size 
SD= Standard deviation of 
the mean 
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The values of amino acids at birth are compared '-lith cord amino 
acid values for preterm infants (30-36 weeks) published by Ghadimi (1964a). 
The amino acid values at JO days are compared '-lith values for infants 1-3 
months published by Snyderman (1968) on a diet 'With similar protein intake 
(J,0-3)5 g/kg/day) . 
RANGE 
Of particular note is the wide ran~-e of values for each amino 
acid estimated in the LBM infant, Fig . 56 shows the mean values and ranges 
of plasma amino acids at birth. 
Fi g. 56. 
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Furthermore, there i.ra.s an increase in the 'Width of the range 
for each amino acid by JO days follo'Wing prolonged milk feeding. Fig. 57 
shows the mean values and ranges of plasma amino acids at JO days. 
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(b) The effect of milk feeding. 
By continuous nasogastric milk feeding the maximum volume of 
milk (200ml/ke/day) was achieved by the 5th day. This represented a 
protein intake of 3,2 g/kg/day, similar to the protein.:htake of infants 
on breast milk . Alterations in amino acid patterns in the plasma occur 
within 24 hours of altering the protein intake (Snyderman, 1968 ). It is 
thus assumed that- estimations of plasma amin~· acids on the tenth day 
represent a relatively stable pattern. The values of plasma amino acids 
of the ORAL group on the tenth day are shown in Table :.XXX. Table XXX 
compares the amino acid equivalents per kg infant mass available by means 
of Nan (200 ml/kg/day), Amigen (80 ml/kg/day) and breast milk (200 ml/kg/day) 1 
TABLE XXX . 
COMPARISON OF ESSENTIAL AMINO ACID I NT.AKE OF NAN, 
AMIGEN AND BREAST MILK 
(Expressed in micromoles per kg) 
ORAL PARENTERAL 
AMINO ACID 200 ml NAN 80 ml AMIGEN * 200 ml breast milk 
THREONINE 1450 660 1040 
VALINE 1500 1062 1540 
METHIONINE 470 392 310 
, 
ISOLEUCINE 1470 752 1310 
LEUCINE 2700 1709 2460 
TYROSINE 300 164 , 240 
PHENYLALANINE 720 567 780 
LYSINE 1750 1426 1080 
HISTIDINE 390 540 JOO 
* As analysed by our Laboratory (See Table XXXI) 
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(c) The effect of Total Parenteral Nutrition 
The parenteral solution of casein hydrolysate (Amigen), fat 
emulsion (Intralipid) and 50% dextrose water with supplementary multivitamin 
infusion has been described in detail in Chapter II. A total of 150 ml/kg/day 
of the solution vas infused, providing a maximum of 136 cal/kg/day. The 
actual volume of Amigen 5% given vas 80 ml/kg. · The amino acid concentration 
of 80 ml Amigen ~s compared vith the concentration provided by 200 ml milk 
in Table XXX. It vill be noted that the protein intake vas the same in 
the ORAL and PARENTERAL groups per kg/day. In addition , the actual intake 
of amino acids by oral and parenteral route is remarkably similar . 
In practice , however, analysis of the commercial solutions of 
amino acids reveals that there is considerable variation iri the concentration 
of amino acids from that specified by the manufacturer (Stegink, 1971). 
The mean values of our analysis of random samples from three separate batches 
of Amigen are compared in Table XXXI Yith the manufacturer's specifications 
and values obtained by Stegink and Baker for the same preparation (Stegink, 
1971). 
1 1 9 
TABLE XXXI 
AMINO ACID C.ONCENTRATION IN AMIGEN 5% IN DEXTROSE WATER 5% w/v 
(Expressed in micromoles/100 ml) 
AMIGEN AMIGEN AMIGEN 
* 
(Our lab.) (Stegink) 
ASPARTIC ACID 1804 402 500 
'• 
THREONINE 1176 
-824 992 
SERINE 2285 1422 · 1900 
GLUTAMIC ACID 552 1290 1960 
PROLINE 675 413 1280 
GLYCINE 266 416 758 
ALANINE 2359 1067 1109 
CYSTINE 
-
trace 0 
I 
VALINE 2645 1328 1686 
'METHIONINE 870 490 754 
ISOLEUCINE 1830 940 1365 
LEUCINE 2976 2136 2960 
TYROSINE 
- 205 234 
PHENYLALANINE 1212 708 1182 
LSYINE 1780 1783 2493 
HISTIDINE 649 675 631 
ARGININE 919 164 165 
* Specifications on Amigen label (approximate) 
++ Analysis of Amigen by Stegink (1971) . 
++ 
TABLE XXXI. · Analysis of Amigen by Stegink and Baker and also by our 
laboratory illustr~tes the wide variability of free amino acids encountered 
in this solution. 
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The levels of free amino acids in the plasma of infants in 
the .PARENTERAL group after 9 days of TPN are compared with levels found 
in the ORAL group fed solely with milk in Table XXXII . 
TABLE XXXII 
AMINO ACID 
ASPARTIC ACID 
THREONI NE 
SERINE 
GLUTAMIC ACID 
PROLI NE 
GLYSINE 
ALANINE 
CYSTI:NE 
VALINE 
METHIONI NE . 
ISO LEU CINE 
LEUCINE 
TYROSH'l'E 
PHENYLALA.t'UNE 
LYSINE 
HISTIDINE 
ARGININE 
PLASMA AMINO ACIDS AT 10 DAYS 
(Expressed as micromoles/100 ml) 
ORAL PARENTERAL 
n = 9 . n = 10 
Mean + S.D Mean + - - S.D. 
5,30 1, 19 11,47 2,09 
33,15 5,96 34,98 3 ,19 
39,85 5,58 57,58 6,36 
39,71 6.,84 65,31 7,30 
19,06 4,34 33,75 5,57 
47,66 5,76 50,96 6,02 
45,45 7,02 52,61 9,82 
2,22 o,75 12,87 3,70 
14,.31 3,64 21,25 4,42 
19,95 7,12 20,27 6,77 
6,25 1,12 15,50 3,79 
9,85 1.,65 26,91 6,45 
7,18 1,57 8,74 2,35 
7,19 o,86 13,05 2,17 
28,92 5,61 41,12 5,94 
10,74 3,18 18,0l 5,72 
4,25 1,39 4,03 0.,71 
n = sample size 
' 
S. D. = Standard deviation of the mean 
p VALUE 
p < ,05 
p < ,05 
p < ,02 
p < ,05 
p < ,001 
p < ,05 
1 2 1 
1 2 2 
There was a significant statistical difference in 6 instances , 
I 
viz Aspartic acid , glutamic acid , cystine , i soleucine , leucine and 
phenylalanine . These ami no acids ,were all signi fi cantl y raised above the. 
l evel s obtained i n t he ORAL group. 
Fig . 58 shows that there is a general t r end f or the ma jority of amino 
acids t o be elevated during TPN. However, most of t hem fal l within the 
standard deviation of the mean values f or tpe ORAL group . 
signi fi cantly elevated are indicated . 
Fig. 58 
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(d) Plasma amino acids at 30 days. 
From the 11th day , TPN was replaced by introducinG oral feeding, 
and from the 14th day onwards both groups (ORAL and PARENTERAL) were 
fed in the same manner . The plasma amino acid values for the ORAL 
8roup at 30 days appear in Table XXIX. It was important t o establish 
whether amino acid levels which were gener ally raised in the PARENTERAL 
group at 10 days had returned to the same level as those obtained in the 
ORAL group at 30 days . 
Fie . 59 compares the mean values of amino acids in the plasma 
of the ORAL and P.ARENTER.fl, groups at 30 days. 
Fig . 59. 
PLASMA AMI OACIDS - . AT 3() DAYS 
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CJ PARENTERAL 
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I 
It will be noted that there is no significant difference in 
mean amino acid values f or any of the 17 amino acids of either group by 
30 days . (p .> ,05) 
Moreover, there was no statistically significant .difference 
between overall values of amino acids at birth and at JO days (p ),05) . 
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(e) Individual amino acid s 
The day-to-day fluctuations of individual amino acids in the 
plasma were not studied. However, t he patt ern of each ami no acid f rom 
birth to 30 days i s displ ayed in Appendi x, Fi gs • . 2 t o 18. The ORAL and 
PARENTERAL group values (0 and P) for each amino acid were plotted 
separ ately . There was no significant difference between the values f or 
the two groups either at birth or at 30 days, . The significant st atistical 
dif ference in values between the two groups at 10 days is indicated . 
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4. COMMENT 
A - PLASMA AMINO ACIDS AT BIRTH 
Compared wi~h full term infants, the values of plasma amino 
acids in preterm infants, and especially infants of very low birth mass 
are subject to greater fluctuation and a wider range in concentrations 
(Ghadimi, 1964b). This was a notable feature in this study (see Table 
XXIZ Figs . 56, 57 and 59). 
The values for threonine , praline, alanine, cystine, isoleucine, 
leucine , tyrosine and arginine are within the normal range for infant s 
(Snyderman and Holt, 1968), whereas those for aspartic acid, serine, 
glutamic acid, glycine, methionine, phenylalanine, lysine and histidine 
are elevated , corresponding more closely to the cord values for preterm 
infants (Ghadimi and Pecora, 1964a). The plasma level of valine is lower 
than both the cord value and the value at one month (see Table XXVI) 
High levels of aspartic and glutamic acid could be explained 
by immaturity of the enzymes required for the Kreb 1 s cycle resulting in 
increased foetal levels of these amino acids which are reflected in the 
plasma levels on the first day of life. The observation (Schreier, 1955) 
t hat a high percentage of very small preterm infants have significantly 
increased levels of lysine and phenylalanine was substantiated. Lysine 
is important in nitrogen metabolism in infants and the level is dependent 
solely on the protein intake - this explains why the level falls in subsequent 
days after birth (Ghadimi, 1964b). 
Hist idine levels are raised in the cord blood (and presumably on 
the first day of life) due to inadequate renal function (Schreier, 1955). 
Although tyrosine levels may be elevated within a few days after 
birth (Schreier, 1955 ; La · Du, 1963), the level at birth was within the 
normal range f or infants. 
Serine and glycine levels after birth were reported to be within 
the normal range (Ghadimi, 1964b). In this study levels of these two amino 
acids were substantially higher than either cord or infant levels. This is 
probabl y explained by the wide variation found in the levels, and also by the 
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fact that the level of amino acids is highest in the youngest and smallest 
foetuses (Li chtenstein, 1931). 
Ghadimi has reported raised and even abnormally high levels of . 
methionine in preterm infants (Ghadimi, 1964b). In this study the level · 
was consistently raised throughout the first month. 
Elevations in plasma amino acids after birth have been reported 
in M.mulatta (the· Rhesus monkey) born prematurely. These reached normal 
limits by the end of the first postnatal month (Kerr, 1968). In contrast 
to this, levels of aspartic acid, serine, glutamic acid, glycine , methionine, 
isoleucine, lysine and histidine were still great.er than normal infant 
values at 30 days in this study. (See Table XXIX). 
B - THE EFFECT OF MILK FEEDING ON PLASMA AMINO ACID CONCENTRATION 
The requirements of all the essential amino acids were being 
adequately met by the amino acid concentration in 3.2 g/kg/day of the Nan 
milk formula (Table XXI). The minimum daily requirements of essential 
amino acids appear in Appendix, Table XXIX • . 
Plasma levels may conceivably be affected by several factors: 
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by ease of assimilation, by the need for the amino acid, by the rate of 
degradation of unutilisable surpluses and by the rate of renal excretion. 
(Snyderman, 1968). With the removal of maternal and placental control and 
perhaps the initiation of certain catabolic pathways, as well as the introduction 
of microorganisms into the gastrointestinal tract, and the increasing output 
of digestive proteolytic enzymes, a wider range in concentration results 
(Ghadimi, 1964b). This was noticed in this study (Table XXIX). 
Despite the increase in range of concentrations after the 
introduction of milk feeding the only significant alterations occurred in 
threonine and cystine levels. There was a significant increase in plasma 
threonine and decrease in plasma cystine at 10 days from those levels recorded 
at birth (p( 105). (See Table XXIX). The reason for these changes is not 
obvious, but it may be related to the amino acid composition of the Nan. 
Certainly, the threonine content is twice the minimal daily requirement. 
Cystine levels of Nan have not been published, but it is possible that, -as in 
breast milk , they are low. Both amino acids attain normal concentrations· 
by the 30th day . There are no significant changes in concentration for any 
of the amino acids at 30 days. 
It appears therefore, that the amino acid composition of Nan 
"humanised" milk, except possibly for cystine, is satisfactory in meeting 
t he r equirements of the LBM infant. Cystine has been regarded as an 
essential amino acid in the human foetus (Raiha, 1971) as cystathionase 
activity does not appear until after birth (Gaull, 1972 Pascal, 1972) . 
Approximately 22% of the methionine requirements can be me\ by cystine. 
Br east mi lk provides a meager margin of safety in this respect (Albanese, 
1949). It would appear that a diet iTith adequate cystine is essential 
for the immature newborn. The higher cystine levels at 30 days are probably 
due to the fact that cystathionase is present in normal amounts. 
Snyderman and Holt reported the paradoxical behaviour of glycine 
with varying protein intake (Snyderman and Holt, 1968). When the intake 
is high (9 g/kg/day), glycine levels are low, but at the level of 
3,5 g/kg/day glycine levels tend to be raised. The glycine levels in this 
study were above those given for infants 1-3 months of age (See Table XXIX). 
with a protein intake of 3,2 g/kg/day. 
C - PLASMA AMINO ACIDS DURING TOTAL PARENTERAL NillRITION 
(a) The oar enter a l f luid 
Stegink showed that the plasma amino acids in infants during TPN 
closely resemble the infusate in proportions (Stegink, 1971). Our analysis 
of casein hydrolysate (Amigen; Table XXXI) showed large amounts of glutamic 
acid and aspartic acid . The phenylalanine~tyrosine ratio was approximately 
3:1. A trace of cystine was detectable. 
(b) Pl~nmn nm l no ~cid s 
I t mus t bo emphnsised that these ' o.mino acid l evels wer e entimatcd 
f rom samples withdrawn during infusion. Elevation of amino acids have been 
reported during infusion , particularly methionine, lysine, threonine, serine, 
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elycine, leucine (Ghadimi , 1971a) valine, proline , isoleucine . and 
phenylalanine (Wei, 1972). The l evels may be explained by higher rates 
of administration (Ghadimi, 1971a) or possibly by immature enzyme systems. 
(Das, 1970) . Levels exceeding twice the normal value (Ghadimi , 1971a) or 
higher (Wei, 1972) have been found. A comparison of the amino acids at 
10 days with those values obtained by Wei during peripheral vein TPN 
appears in Table ·x:xxIII. 
TABLE XXXIII . 
PLASMA AMINO ACIDS DURING TOTAL PARENTERAL NUTRITION 
AMI NO ACID 
ASPARTIC ACID 
THREDNINE 
SERINE 
GLUTAMIC ACID 
PROLI NE 
GLYCINE 
ALANINE 
VALINE 
METHIONINE 
ISO LEU CINE 
LEUCINE 
TYROSINE 
PHENYLALANDIB 
LYSINE 
HISTIDINE 
ARGININE 
(Expr essed as micromoles/100 ml) 
+ 
MEAN Parenteral gr. WEI, 1972 MEAN NORMAL MEAN * 
11,47 017 1,0 
34,98 19,2 7,6 
57,58 16,2 9,4 
20,68 9,3 12,4 
33,75 49 ,0 10,6 
50,96 21,5 16,7 
52,6 32.,2 23,5 
21,5 37,7 16,2 
20.,27 ?,o 1,4 
15,5 10,2 4,4 
26,91 18,3 8,5 
8,74 ' 6,5 4,3 
13,05 9,9 3,8 
41,12 24,2 11,2 
18,0l 8,3 3,7 
4 ,03 5,7 5,3 
+ Wei, P (1972) Mean values during parenteral nutrition 
of neonates. 
* Scriver, C.R., and Davies, E. (1965 ) 
Normal plasma amino acid values of infants below 3 months 
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Despite the general elevation, only 6 amino acids were significantly 
elevated over the values obtained for the ORAL group: aspartic acid, 
gl ut amic acid, cystine, isoleucine, leucine and phenylalanine. 
Cystine, while not markedly elevated, "7as higher than the ORAL 
group whose level was lo"7er than fasting values. The reason for the elevation 
is not clear, but is probably explained by. the fact that traces were detected 
in the infusate, and there may have been conyersion from cysteine to cystine 
in the infusate. Most authors (Steiink, 1971; Wei, 1972) report low levels 
of cystine during TPN. 
Aspartic acid and glutamic acid levels probably reflect the large 
amounts present in the infusate. These high levels are of'. particular 
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concern, as acute and irreversible changes in the mouse retina have been 
reported following subcutaneous injection of either aspartic acid or monosodium 
glutamate (Freedman, 1967) and especially in the newborn (Lucas, 1957). 
However, large doses per kg were used in these experiments (Olney and 
Sharpe, 1969) and even when plasma glutamate was 3 times the normal value, 
brain glutamate levels were not affected (McLaughlan, 1970). Though not 
dispensing with the possible detrimental effects of raised plasma values, 
I did not observe any demonstrable evidence of central nervous system 
damage or alteration in clinical state. 
An increase in the ambient tissue levels of a number of amino 
acids, including phenylalanine, may interfere "11th the normal develoµnent 
of the infant rat brain. The formation of brain sulphatide is inhibited 
by high levels of phenylalanine, methionine, tyrosine, arginine and to a 
lesser extent leucine and valine (Chase, 1970). Transitory hyperphenylalanin-
aemia with values exceeding 20 mg% has been described by Bremer (Bremer, 
1971). Values during TPN approximated 2 mg% and returned to normal once 
TPN "18.S discontinued. 
Hypertyrosinaemia "18.S not observed. Little is known of the attendant 
clinical states (if such exist) of subacute amino acid toxicity or antagonism. 
The inf usate, in terms of protein load, was not excessive, yet the general 
elevation of amino acid concentrations is .disturbing. 
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It is gratifying to note that amino acid levels, after TPN,(at 30 days) 
do not differ significantly from the ORAL group. This was also reporte~ 
by Ghadirni (1971a). 
CONCLUSION 
The plasma amino acid values at birth, and throughout the first 
post-natal month in vezy-LBM infants are subject to a wider range of 
concentrations and greater fluctuation than normal term infants. Values 
for aspartic acid, serine, glutamic acid, glycine, methionine, phenylalanine, 
lysine and histidine are elevated after birth. Plasma valine is lower th.an 
normal at birth. At the end of the first post-natal month, levels of 
these amino acids are still higher than normal term infants with the 
exception of phenylalanine. 
The introduction of milk feeding produces an increase in the range 
·or concentrations of the amino acids, but only threonine is significantly 
raised at 10 days, while cystine levels are significantly decreased. Both 
these amino acids attain normal concentrations at one month. The amino 
acid concentration of Nan appears satisfactory except possibly for cystine 
which may be present in inadequate amounts. 
During TPN with casein hydrolysate, there is a general elevation 
of most amino acids. In particular, aspartic acid, glutamic acid, cystine, 
leucine, isoleucine and phenylalanine are significantly raised compared with 
controls receiving Nan orally. The danger of elevated glutamic acid and 
aspartic acid levels has been shown experimentally when higher concentrations 
of these amino acids have been infused. No clinical or neurological 
manifestations were observed in these infants, but the danger of subclinical 
toxic states cannot be excluded. 
The concept of essential and non-essential amino acids does not 
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apply to TPN where the portal venous system and liver are by-passed. (Schreier, 
1955; Stegink, 1971). 
Current amino acid solutions a.re not specifically intended for use 
in the paediatric patient requiring TPN. 
Perhaps in the future, a parenteral solution of free amino acids 
suitable for paediatric (and especially for neonatal) use will become 
available, the composition being determined by the minimal daily requirements 
of the individual amino acids, and directed towards achieving plasma amino 
acid values within the accepted normal range. 
Until such time, the use of parenteral amino acid solutions in 
the neonate, and particularly the low birth mass infant, should be 
regarded as experimental. 
i 
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5. SUMMARY 
1. The plasma amino acid concentration at birth, 10 days and 1 month were 
estimated in 25 low birth mass infants. 
2. Of these, 10 infants were fed by an infusion of amino acids in the form 
of casein hydrolysate through the umbilical artery for the first 10 days. 
3. The normal range of plasma amino acid values for low birth mass infants 
is given which shows a wider range in concentrations than that obtained 
for full term infants. 
4. During TPN the plasma amino acid values were generally elevated above 
t hose obtained in infants receiving conventional milk feeding with a 
humani sed milk formula. In particular, the concentrati.ons of aspartic 
acid, phenylalanine, cystine, leucine, isoleucine and glutamic acid 
were signif icantly higher. 
5. With the cessation of TPN, these levels returned to normal so that no 
significant difference could be detected between these groups at one 
month. 
6. The suitability of current amino acid solutions for paediatric use is 
discussed. 
7. In view of the elevations of certain amino acids above normally accepted 
limits during TPN in LBM infants, this procedure must be regarded as 
I 
experimental until the significance of these elevations is made clear. 
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CHAPTER VI 
THE FOLLOW-UP 
1. MORTALITY AFTER 28 DAYS 
2. MORBIDITY AFTER DISCHARGE 
3. NEUROLOGICAL ASSESSMENT 
4. COMMENT 
THE FOLLOW UP 
This study was primarily concerned with the in-patient management 
of these infants for the neonatal period, but it was thought that the 
later status of the infants -would also be of interest and the early follow-
up studies follow . 
Interpretation of the results to qate must take into account 
the fact that many of -the infants have not yet reached 6 months of age, 
but the general trend may be of interest. 
Table XXXIV indicates the present status of the follov-up programme. 
TABLE XXX!V 
PRESENT STATUS OF FOLLOW-UP PROGRAMME 
Deaths within the first 28 days I 15 
Deaths after the first 28 days 10 
Infants lost to follov up 4 
Infants followed at intervals 57 
TOTAL 86 
Details of the infants who died within the first 28 days have 
been discussed (Chapter III page49) 
(1) Mortality after 28 days 
Ten infants died after 28 days and before 7 months of age. The 
cause of death is sho'Wll in Table XXXV. 
TABLE XXXV 
MORTALITY AFTER 28 DAYS (10 INFANTS) 
Broncho-pneumonia 6 cases 3 at home 
. Necrotising enterocolitis 2 cases in hospital 
Hydrochephalus 1 case in hospital 
Wilson-Mikity syndrome 1 case in hospital 
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Seven of the 10 deaths occurred in hospital, i.e. the infants 
were never discharged home. 
(2) MORBIDITY after discharge 
A high morbidity has been seen in the surviving infants as 
indicated in Table XXXVI. 
'TABLE XXXVI 
MORBIDITY AFTER DISCHARGE 
Bronchopnewno,""'-a 8 cases 
Recurrent bronchospasm 5 cases 
Gastroenteritis 4 cases· 
Inguinal hernia 5 cases 
Meningitis 1 case 
Hydrocephalus 1 case 
Whooping cough 1 case 
Unilateral renal agenesis 1 case 
The incidence of serious disease -was 45,6% (26/57,infants). 
Respiratory infections were the commonest cause of illness, and necessitated 
· hospital admission. The infants with gastroenteritis required admission 
for rehydration and treatment. In 2 infants the course of the gastroenteritis 
was severe and prolonged, necessitating TPN for more than 2 weeks at Red Cross 
War Memorial Children!s Hospital. They made a satisfactory recovery and are 
progressing normally. 
One infant had large bilateral inguinal herniae which required 
surgical repair. The inguinal herniae are possibly secondary to respiratory 
infections so commonly seen in preterm infants, or to weak abdominal wall 
musculature . Arrangements have been made for the insertion of an atrio-
ventricular shunt in the infant who developed hydrocephalus at the age of 6 
months . The unilateral renal agenesis was discovered after pyelonephritis 
had been diagnosed in one infant. 
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(3 ) Neurological as sessment 
A protocol for neurological assessment (Appendix, Table:XXX) 
was dra\.Jil up, incorporating the gross motor examination as proposed by 
Milani-Comparetti and Gidoni (1967). In addition, vision and fine motor 
coordination, hearing and language, and social behaviour were observed. 
The importance of .vision and hearing testing in infancy has been atr~ssed 
by Sheridan (1969). Each infant was carefu.ily examined for signs of cerebral 
palsy as outlined by Illingworth (1966). 
Infants were assessed at 6 weeks (usually before discharge from 
hospital), 3 months, 6 months and 1 year. The assessments were done jointly 
by Dr. C. Molteno and myself. In addition, the social worker was in attendance 
to speak to the mother and assist with problems. 
An estimate of the neurological status of the 57 infants attending 
follow-up to date appears in Table XXXVII. 
TAB LE XXXVII 
DEVELOPMENTAL ASSESSMENT 
Infants attending follo'W'-Up No. Normal Doubtful Abnormal 
clinic 
(a) Assessed at 1 year 12 11 l 
-
(b) Assessed at 6 months 27 24 2 1 
(c) Assessed at 3 months 
' 
18 16 l l 
TOTAL . 57 51 4 2 . 
Two infants have been assessed as abnormal before the first year. 
One, with gross evidence of intrauterine gro'W'th retardation, exhibits a marked 
increase in extensor tone. The other, 'W'hO 'W'8.s admitted to hospital with 
protracted gastroenteritis, was also small for gestational age at birth and 
exhibits increased tone, particularly of the necx extensors. 
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Four infants have been assessed as of doubtful neurological status. 
In each there is evidence of increased tone which may, in our experience, still 
disappear on further assessment. 
Fifty-one infants were considered as having developed normally 
taking gestational age into account and had no gross neurological deficit. 
Noreof the 57 inf.ants have developed convulsions. 
(4) Comment 
There is an increased susceptibility to lower respiratory tract 
infections in prematurely born children (Drillien, 1964). In particular, 
recurrent attacks of bronchospasm associated Yith lower respiratory infections 
are common. The risk of gastro-intestinal infection in preterm infants 
increases as maternal care deteriorates (Drillien, 1964). This could be said 
to be true for 3 of the 4 mothers whose infants were admitted to hospital 
Yith protracted gastro-intestinal infection. 
The incidence of mental and physical handicaps in infants of birth 
mass less than 1500 g (3 lbs.) is generally reported between 32 and 35% 
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(Harper, 1959; Dann, 1964; McDonald, 1967). Lubchenco (1972a) in her 10 year 
assessment, demonstrated a relati~nship between these handicaps and previous 
nursery practices of high ambient oxygen levels and delayed feeding for low 
birth mass infants. Her incidence of handicap -was 70%, including eye defects. 
She also reported a relationship between low calorie intake and low intelligence 
quotient. 
Neurological sequelae are commoner in small for gestational age than 
appropriate for gestational age infants (Bacola, 1966; Dunn, 1971). Both the 
abnormal infants in this study were SGA and were born of mothers Yith severe 
pre- eclamptic toxaemia. With the advent of intensive care, the prognosis for 
very low birth mass infants is changing (Rawlings, 1971). The University 
College Hospital follow-up study of infants 'With birth mass between 1001 and 
1500 g reported a neonatal survival rate of 73%. Of the 68 infants, 59 (86. 7% ) 
were assessed as normal, 4 (5.9%) doubtful and 5 (7.4%) abnormal between the 
ages of 9 months and 4. 25 years. 
While no conclusions can be draYn from the early findings in this 
study, the pattern would appear to be similar to that described by Rawlings 
(1971). 
Final outcome must await detailed assessment at school-going age. 
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CHAPTER VII 
CONCLUSIONS 
CONCLUSION 
Eighty-six infants of birth mass less than 1500 g ~ho showed no 
evidence of clinical illness within th6 first twenty-four hours of birth were 
included in this study and allocated to an ORAL or PARENTERAL group by 
random selection. 
The ORAL group were fed with humanised milk by continuous intra-
gastric drip until a maximum volume of 200 ml/kg/day and maximum energy intake 
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of 142 cal/kg/day was achieved. The PARENTERAL group : were .fed exclusively with 
a solution of casein hydrolysate, dextrose ?Jld fat emulsion providing 136 cal/kg/ 
day at a maximum volume of 150 ml/kg/day. This was give_n via an umbilical 
artery previously cannulated. The parenteral infusion continued for +O days 
after which time the infants were given humanized milk by continuous ~asogastric 
tube feeds. There was no significant difference in birth mass, sex incidence, 
gestational age, mortality rate, incidence of morbidity and Apgar scores between 
the two groups. 
The overall mortality was 17,4% (ORAL 14%; PARENTERAL 20,9%). 
The mortality rate was highest in infants of lowest gestational age. No 
deaths occurred in those infants who were judged to be SGA (14). Only one 
death occurred in an infant of more than 30 weeks gestation. Compared with 
previous mortality rates the mortality rate for both groups was considerably 
reduced, which can be attributed to the beneficial effect of intensive care 
nursing. The Apgar score at one minute Ya.S related to better survival rates. 
Conversely, the Denver Death Model Score did not predict the possible outcome 
of these infants, possibly because the group Yas selective. 
There was no significant difference in mortality between the two 
groups, neither was a difference in the neonatal morbidity detected, apart 
from the higher incidence of catheter complications in the PARENTERAL group, 
none of ~hich proved fatal. The occurrence of catheter complication appears 
related to the duration of catheterisation. The incidence of apnoea in the 
first 10 days following birth is associated with increased .mortality. There 
also . a~pears to be an association between the frequency of vomiting and 
apnoeic attacks. Nevertheless, although there was a much lower incidence 
I 
of vomiting in the PARENTERAL group, no difference in the incidence of apnoea 
was found between the two groups. 
There was also no significant difference in the rate of growth 
over the first 6 weeks between the two groups as judged by mass, length and 
head circumference. The daily rates of grow,th were not able to compare with 
the st andard intrauterine growth rates... . Appropriately grown--i nfants 
fol l owed t he 25th percentile for all three parameters, while SGA 
infants were below the 10th percentile for mass and length, only the head 
circumference showing signs of catching up at 6 weeks. 
The contribution of IV fluid to mass gain must be taken into account 
especially in those infants less than 1000 g at birth. As a crude clinical 
estimate, it was found that the energy requirement of ~nfants less than 
1500 g is between 110 and 130 cal/kg/day. A daily IV volume of 100-120 ml/kg 
would appear to be suitable for the first week. 
Severe hyperbilirubinaemia was not encountered in this study, 
probably due to the early employment of continuous phototherapy at relatively 
low total serum bilirubin levels (6 mg%). It is hoped that the consequences 
of hyperbilirubinaemia may have been avoided. 
No differences in acid-base levels between the tyo groups were 
observed. A late type of metabolic acidosis was seen in many infant s. TPN 
infusion had no significant effect on acid-base homeostasis in these infants. 
The dextrose-amino acid infusate appeared to meet the electrolyte, 
calcium, phosphate and mineral requirements of the inflnts studied, and did not 
result in serious biochemical abnormalities. During TPN, the values for 
serum sodium, potassium, chloride, calcium and phosphate were within normal 
limits, although those obtained for potassium and calcium were significantly 
1 4 0 
higher in the PARENTERAL group. The effect of the osmolar load of the infusate 
was sho'IJZ'l in a significantly higher serum osmolality (within the upper range 
of normal). Hyperglycaemia and glycosuria during TPN was infrequently 
observed. Although no glucose was infused during the five hours of intralipid 
infusion, blood glucose levels remained within normal limits. Biochemical 
values of urinary electrolytes, urea and osmolality reflected changes in the 
serum and indicated adequate renal function in these low birth mass infants.· 
Of particular concern was the finding of markedly raised serum · 
cholesterol levels during IV fat emulsion infusion. Although these levels 
returned to vi.thin normal limits once the infusion was discontinued, the 
possible effect of hypercholesterolaemia in these infants requires further 
investigation and lower concentrations of Intralipid should probably be 
used until the significance of these levels is understood. 
A high incidence (41%) of placental infect ion and presence of 
significant amounts of pus cells in the gastric aspirate (25%)· was documented, 
and would serve in part as an explanation for the high mortality and morbidity 
enc9untered i n these infants. There wasapositive corr elation between 
the presence of placental infection and the presence of infection in the 
gastric aspirate. In addition a strong association between placental infection 
and mortality was shown. Of bacterial cultures from multiple sites after 
birth, the highest yield was found from cultures taken from the ear. The 
results of these investigations should be regarded as suspicious of, but not 
diagnostic of, imminent sepsis in the neonate. Rational antibiotic therapy 
should be based on the information derived from the histologic examination 
of the placenta , microscopic examination of the gastric aspirate and culture 
of the ear swab. No difference in the incidence of sepsis between ORAL and 
PARENTERAL groups was noted. 
A finding of major importance in this study was that of elevated 
amino acids in the plasma during infusion of amino acids in the form of 
casein hydrolysate . In particular, the concentrations of aspartic acid, 
glutamic acid, cystine, Jeucine, isoleucine and phenylalanine were significantly 
higher than those obtained in infants fed with humanized milk feeds. With 
the cessation of TPN these levels returned to within normal limits. The 
normal range of plasma amino acids at birth has been determined, and shown 
to be subject to a wider range in concentrations than normal full term infants. 
1 4 1 
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The suitability of current amino acid solutions for paediatric, and particularly 
neonatal , use is discussed. It is hoped that in the near future a parenteral 
solution of free amino acids, the composition of which is determined by the 
minimal daily requirements of the individual amino acids, will become 
avilable. Until such time, the use of parenteral amino acid solutions 
in the neonate, and particularly the low birth mass infant, should be 
regarded as experimental. 
Was the project a worthwhile subject for study.' ·'. It is the 
author's opinion that it was for the following reasons -
(a) TPN has not been shown to ~ave significant advantage oyer conventional 
milk feeding practices in the low birth mass infant. This is of importance 
in a developing country where sophisticated facilities are limited to a 
few large centres, and shows that the mortality rate of these infants can 
be lowered with conventional routines and additional care to nursing detail. 
(b) With the facilities of modern intensive care, mortality and morbidity 
in low birth mass infants can be reduced. 
(c) . With the reduction in morbidity, the subsequent mental and motor 
development of these infants appears to be improving. Although no 
conclusions can be drawn from the early follow-up findings in this study, 
the pattern would appear to be similar to that described by others 
(Rawlings, 1971). Final outcome must await detailed assessment at school-
going age. 
(d) A significant proportion of these infants are planned or precious and 
every effort must be made to provide the mother with a normal, healthy 
infant. The experience gained from planning a comprehensive care 
programme after discharge has been valuable in itself. 
(e) A study of the perinatal infective environment has confirmed the large 
contribution towards morbidity and mortality made by infection. Earlier 
detection and more rational treatment of infection is necessary in the ;: 
management of these infants. 
(f) There is a place for TPN in sick low birth mass infants where the oral 
route must temporarily be by-passed. In necrotising enterocolitis, 
severe hyaline membrane disease (especially when the infant is on assisted 
ventilation) and septicaemia, it is possible to provide the infant with 
the necessary energy by parenteral route, especially if the illness is 
prolonged. 
(g) Two possible dangers of TPN have been demonstrated - that of hyper-
cholesterolaemia during fat infusion and of hyperaminoacidaemia during 
infusion with free amino acids. 
(h) TPN has been shown to be capable of supporting growth in low birth mass 
infants, and it has been possible to estimate clinically the amount of 
energy required to support such gro\lth. 
(i) Ultimately this searching question will be answered/ more accurately 
by the 10-year prospective developmental assessment already in progress. 
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APPENDIX 
STATISTICAL MEI'HODS. 
TABLES I to XXX. 
FIGURES 1 to 18. 
I 
STATISTICAL METHODS 
The statistical analysis of the d~ta presented in this thesis was 
performed by Mr. G. van der Merwe of the National Institute for Nutrition . 
and Metabolic Diseases, Medical Research Council,·Pretoria. 
The arithmetic mean (~ean) and the mean quadrantic deviation 
(standard deviation) were determined on all collective samples. 
The significance of the difference-of the two means was calculated 
by dividing the difference of the means (x - "'i) by the standard deviation 
of the difference of the means. In all cases the standard deviation of the 
difference of the means was calculated for small samples. 
Confidence limits were expressed at the 95% level and determined 
for small samples as the mean (x) ~ significance (t) X standard error. 
The Chi-square test (x2distribution) ldth Yates correction was 
used to determine the significance of the difference of , two parameters 
between the t\.10 groups. 
When determining the significance of the difference of two 
parameters involving small frequencies, the Fisher Exact Probability Test 
was used. (Armitage, 1971). 
APPARATUS APPENDIX TABLE 1 
A - Apnoea Alarm Medical and Biological Instrumentation Ltd., Ashford, 
Kent , England. 
B - Ivac Model 501 Constant Infusion Pump: Ivac Corporation, San Diego, 
California, U.S.A. 
C - Tele-thermometer: Yello~ Springs, California, U.S.A. 
D - Beckman Model . C2 and D2 Oxygen analysers . : Beckman Instruments, 
2500 Harbour Boulevard, Fullerton, California. 
E - INFUSION APPARATUS 
1. Soluset BlOO No. 1716 100 ml burette Abbott Laboratories, N. Chicago, 
Illinois 60064, U.S.A. 
2. Plexitron Buretrol 150 ml burette. Code 2coi33. 
J. Plexitron Extension set with final filter Code 2cq240. 
4. Plexitron Pedatrol Controlled volume unit Code 2C0401. 
I 
5. Plexitron Small Vein set Code R35. 
6. Plexitron Paediatric adm.inistration-,·set for solutions (19 drops/ml). 
Code R41. 
2, 3, 4, 5 and 6 from Travenol Labpratories, Deerfield, Illinois 
60015 , U.S.A. 
7. Injection of Protein Hydrolysate (Amigen) 51o m/v and Dextrose 5% m/v. 
Code M 64. (Baxter).. 
8. Injection of Invert Sugar 10% m/v (Travert). 
9. Polyionic No. l .in dextrose 5% m/v (Travert). 
8 and 9 from Baxter Labora~ories Inc., Morton Grove, Illinois, U.S.A. 
10. Argyle Umbilical Artery Catheter 315 Fr. 1511 length: Aloe Medical, 
st. Louis, Montana, U.S.A. 
F - Amino Acid Analyser: Beckman Model 120C, Palo Alto, California, u.s.A. 
.
 I 
B
IR
T
H
 
!i 
W
E
IG
H
T 
I 
I 
K9
 
1
.0
 
1.
s 
2
.0
 
3
.
0
 
-
SU
G
G
E
ST
ED
 
3
5
°c
 
3
4
°c
 
-
-
.
.
 
IN
C
U
BA
TO
R
 T
EM
PE
R
AT
U
R
E 
3
3
°c
 
-
3
2
°c
 
AP
PE
ND
IX
 T
AB
LE
 I
i: 
(H
e
y ,
 
19
72
). 
FO
R 
IO
 D
A
Y
S 
-
-
+
 A
FT
E
R
 
10
 D
A
Y
S
-+
 A
FT
ER
 
3 
W
EE
K
S 
_
,
.
 
A
FT
E
R
 5
 W
EE
KS
 
-
-
-
FO
R
 
10
 D
AY
S 
_
,
.
 
A
FT
E
R
 1
0 
DA
YS
 
-
+
 A
FT
E
R
 4
 W
EE
KS
 
-
-
.
 
FO
R
 2
 
D
AY
S 
-
.
 
A
FT
E
R
 2
 
D
AY
S 
_
_
.
 
A
FT
E
R
 3
 W
EJ
;.K
S 
-
-
-
-
-
FO
R
 
2 
DA
YS
 
_
.
 
A
FT
E
R
 
2 
DA
Y
S 
APPENDIX TABLE III 
ACCURACY TESTS YELLOW SPRINGS TELETHERMOMETER 
Six of these temperature thermisters with skin electrodes were 
used for determination of skin temperature throughout the trial. 
In order to determine the accuracY. of these instruments they 
were all fitted with fresh batteries and adjusted according to specifications 
so that when switched off the needle rested opposite the prescribed red 
line. 
All six skin electrodes were immersed in a beaker of water at 
36°c simultaneously. A glass mercury thermometer \.18.S used to determine 
water temperature. 
RESULTS: 
Electrodes I II III - IV V VI 
Readings (oC) 36,4 36,1 35,8 35,7 36,3 3610 
Error% l!>l 0,3 o,6 o,s o,s 0 
These telethermometers exhibited a ~gh degr~e of accuracy. 
APPENDIX TABLE IV 
PATIENT RANDOM SELEGrION TABLE 
0 =ORAL: P = PARENTERAL. 
1. January B p 30. Jacobs p 59. Ghuza 0 
2. January A 0 31. Nasier p 60. Mathe p 
3. Nicholas p 32. Hoffman 0 61. Marco 0 
4. Matthee 0 33. Braaf 0 62. Blows p 
5. Tshemu 0 34. Francke p . 63. Palmer 0 
6. Skorbinski p 35. Benjamin 0 64. Abels p 
7. Brown 0 36. Fisher p 65. Adams p 
8. Titus p 37. Sears 0 66. v.d. Rheede 0 
9. Noncqa 0 38. Darvel p 67. Ndabeni 0 
10. Hartogh p 39. Nolan p 68. Daniels 0 
11. Pilatus 0 40. Petersen 0 69. Thebus p 
12. Thorne p 4].. Ma'Wisa 0 70. Schloss p 
13. Rhoda p •. 42. Thenz.e p 71. van Briesies P 
14. Waldick 0 43 . Isaacs (b) p 72. Kemp 0 
15 . Jacobs o. 44. Baatjies 0 73. Begg 0 
16. Schoeman p 45. Scheepers p 74. Miller p 
17. Wagner p 46. May A 0 75. Benjamin A 0 
18. Isaacs 0 47. May B p 76. Be!ljamin B p 
19. Kock 0 48. Feni 0 77. Maxhela 0 
20. Hamdulay p 49. E:brahiem 0 78. Waggie p 
21 . Europa p 50. Mattheys p 79. Solomons p 
22 . MkYane 0 51. Masalisa 0 80. ·Monk 0 
23. Lusipho p 52. Wyngaard p 81. Faulman A p 
24. Booi 0 53. Marco 0 82. Faulman B 0 
25 . Swartz p 54. Jaffer p SJ. Cryton 0 
26. Williams 0 55. Paulse B p 84. Trouncelle p 
27. Brandt 0 56. Paulse A 0 85. Josephs 0 
28 . Verwey p 57. van Niekerk p 86. Brits p 
29. van Reenen 0 58. Siyayo 0 
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APPENDIX TABLE VI 
PRINCIPLES OF BIOCHEMICAL TECHNIQUES EMPLOYED 
SERUM 
Sodium 
POTASSIUM 
Chloride 
Osmolality 
Calcium 
Protein 
Albumin 
BLOOD 
Urea 
Phosphate 
SGOT 
Cholesterol 
METHOD 
Flame photometry 
titration 
atomic absorption 
method 
Biuret method 
modified by Wol fson (1948). 
brom. crecol green 
diacetyl monoxime 
method (Natelson, 1957) 
Folin + Ciocalteu (1927) 
method 
Liebermann Burchard 
reaction 
Blood glucose glucose oxidase method 
(Marks, 1959) 
Sodium 
Potassium 
Chloride 
Urea 
Osmolality 
Creatinine 
flame photometry 
titration 
Gerhardt's hypobromite 
method 
INSTRUMENT 
Instrumentation Laboratories, 
Inc. Model 143. 
Chloride titrator: American 
Instrument Co., Maryland, USA. 
Knauer Osmometer 
Unica.m S.P. 90 
11Albustrat11 kit test 
Vitatron, Dieren, Holland 
SMA 12/60 Technicon 
autoanalyser. 
Technicon autoanalyser 
Chloride titrator 
Knauer Osmometer 
SMA 12/60 Technicon 
autoanalyser. 
APPENDIX TABLE VII 
DISTRIBUTION OF SMALL AND APPROPRIATE FOR GESTATIONAL AGE INFANTS 
BY GROUP 
Gestational 
Age {Weeks) 
21,0-27,9 
28,0- 29,9 
30,0-31,9 
32,0-33,9 
34,0-35,9 
)36,o 
TOTAL 
INCIDENCE 
% 
ORAL PARENTERAL TOTAL 
SGA AGA SGA AGA SGA 
- 5 - 1 -
-
8 
- 13 -
3 15 1 12 4 
1 6 1 12 2 
; 
4 
- 3 - 7 
1 
- - -
1 
9 34 5 38 14 
9/43 l34/43 5/43 38/43 14/86 
21 79 12 88 16 
.. 
AGA = Appropriate for gestational age 
SGA = Small for gestational age 
AGA 
6 
21 
27 
18 
-
-
72 
72/86 
84 
APPENDIX TABLE VIII 
UNIVERSITY OF COLORAOO MEDI CAL CENTER 
NEONATAL DEATH MODEL 
Encircle the scores Yhich apply and add to get neonatal death score. 
Variable 
Constant 
1. Birth weight 500 grams or less 
501 - 1000 
1001 - 1250 
1251 - 1500 
1501 - 2000 
2001 - 2500 
2501 - .3500 
.3501 - 4000 
4001 or more 
2. Gestational age 27 weeks or less 
28 - 29 
3. Mother's age 
.30 - 31 
.32 - .33 
34 - .35 
36 - 39 
40 - 41 
42 - 43 
44 weeks or more 
Unknown 
Over 40 
4. Previous neonatal death 
5. Fetal deaths (more than 2) 
6. Condition at birth good (Apgar 8-10) 
fair (Apgar 5-7) 
poor (Apgar 0-4) 
7. Toxemia 
8. Fetal distress 
9. Multiple birth 
10. Endo asp or pos press resus 
TOTAL I 
Observed% of neonatal deaths by score 
0 or less o,05% 
1 - 50 o,8 
51 - 150 6, 7 
151 - 250 15,9 
251 - 400 JJ,J 
401 - _ 550 62,5 
551 - 750 75,o 
751 - 1000 96,6 
1001 or more 100,0 
Score 
-12 
686 
611 
364 
144 
75 
14 
7 
0 
14 
217 
80 
44 
22 
7 
2 
0 
5 
7 
7 
23 
175 
1.3 
0 
6 
95 
22 
9 
-49 
14 
·APPENDIX TABLE IX 
DISTRIBUTION OF DENVER SCORE. 
Denver ORAL PARENTERAL TOTAL 
Score Alive Dead Alive Dead Alive Dead 
6, 7% 6 
-
6 
-
12 
-
15,3% 
- -
1 
-
1 
-
15,9% 11 
-
11 
-
22 
-I 
33,0% 1 
- -
1 1 1 
33,3% 7 1 8 2 15 3 
62 , 5% 8 1 5 4 13 5 
75, 0% 3 
-
2 
- 5 -
96,0% 1 
- - -
1 
-
96, 6% 
- 4 1 2 ·1 6 
TOTAL 37 6 34 9 71 15 
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APPENDIX TABLE XXIV 
GASTRIC ASPIRATE IN RELATION TO MORTALITY 
Gastric Aspirat~ Alive Dead Total 
Normal 56 8 64 
Inf ect ed 15 7 i 22 
71 15 86 
This correlation was only significant at the 10% level 
(X2 = J,0076, p ( ,10) and indicates a trend. 
· APPENDIX TABLE YY..V 
DURATION OF RUPTURE OF THE MEMBRANES (hours) 
ORAL PARENTERAL TOTAL 
Mean 46,42 .35,21 40,81 
SD 17,54 10,86 I 10,27 
n 4.3 4.3 86 
SD= Standard Deviation n = sample size. 
An F-test performed on the variances of the ORAL and 
PARENTERAL groups showed no significant statistical difference, 
and therefore at-test could be performed for the differences 
between the two means. At value of 0,024 was found (no 
statistical difference). 
APPENDI X TABLE XXVI 
DURATION OF RUPTURE OF MEMBRANES RELATED TO MORTALITY 
Duration ORAL PARENTERAL TOTAL 
R.O .M. 
(hours) Alive Dead Alive Dead Alive Dead 
I 
0-24 JO 5 24 6 54 11 
)24 7 1 10 3 17 4 
37 6 .34 9 71 15 
p) ,05 
Histology 
(Placenta) 
Non-
Infected 
Infected 
APPENDIX TABLE XXVII. 
DURATION OF RUPTURE OF MEMBRANES RELATED 
TO PLACENTAL HISTOLOGY 
R.O.M. (DURATION) hours 
ORAL .PARENTERAL 
0-24 )24 0-24 )24 
16 2 18 7 
12 5 8 5 
28 7 26 12 
(x2 Total = o,8412 p > ,o5) 
I TOTAL 
0-24 ')24 
34 9 
20 10 
54 19 
APPENDI X TABLE XXVIII 
DURATION OF RUPTURE OF MEMBRANES RELATED 
TO GASTRI C ASPIRATE 
Duration 
of 
R.O.M. (hrs.) 
0 - 24 
) 24 
2 X = o,3908 
I 
I 
GASTRI C ASPIRATE 
Normal Infected 
50 14 
15 7 
65 21 
P),05 
AMINO ACID 
THREONINE 
CYSTINE 
VALINE 
METHIONI NE 
ISOLEUCINE 
LEUCINE 
PHENYLALANINE 
LYSINE 
HISTIDINE 
APPENDIX TABLE XXIX 
}ITNIVLAL DAILY REQUIREMENTS OF AMINO ACIDS 
(Expressed in micromoles/lc~/day) 
MINIMAL DAILY REFERENCES 
REQUIREMENT 
500-730 Pratt·, 1957; Holt, 1961. 
120 Albanese, 1949. 
900 Holt, 1961; Das, 1970. 
302-570 Pratt, 1957; Das, 1970. 
690~910 Albanese, 1948; 
Holt, 1961 
1150 Holt, 1961; Das, 1970. 
550 Pratt, 1957 . Holt, 1961. 
' 
620-710 Pratt, 1957 . Holt, 1961. 
' 
220-230 Holt, 1961; 
Snyderman, 1963. 
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APPENDIX TABLE XXX 
DEVELOPMENTAL EXAMINATION 
Gest. Age: 
Birth weight : 
6wks.3mths.6mths lyr 
Vertical 
Prone 
Supine 
Pull to sit 
-
Sitting 
All fours 
Standing 
Roll over 
Walking 
Hand grasp 
A.T.N. R. 
Moro 
S.T . N. R. 
Foot grasp 
Head in space 
Body in Sagg 
I plane 
Derotative 
Rotative 
Downwards 
Sideways 
Forwards 
Backwards 
Prone 
Supine 
Sitting 
All fours 
Standing 
Vision 
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Index finger 
Pincer 
Lets go 
Cubes 
Hearing 
Vocab 
Command's 
Parts of body 
Pictures 
Smiles 
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Feeding 
Dressing 
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